University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2015

Homologous Recombination-Directed Mechanisms of Alternative
Lengthening of Telomeres
Nam Woo Cho
University of Pennsylvania, namwcho@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Cell Biology Commons, and the Molecular Biology Commons

Recommended Citation
Cho, Nam Woo, "Homologous Recombination-Directed Mechanisms of Alternative Lengthening of
Telomeres" (2015). Publicly Accessible Penn Dissertations. 1655.
https://repository.upenn.edu/edissertations/1655

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1655
For more information, please contact repository@pobox.upenn.edu.

Homologous Recombination-Directed Mechanisms of Alternative Lengthening of
Telomeres
Abstract
Telomere length maintenance is a requisite feature of cellular immortalization and a hallmark of human
cancer. While most human cancers express telomerase activity, ∼10%-15% employ a recombinationdependent telomere maintenance pathway known as alternative lengthening of telomeres (ALT) that is
characterized by multi-telomere clusters and associated promyelocytic leukemia protein bodies. However,
the mechanisms that govern the lengthening process are poorly understood. Here, we show that a DNA
double-strand break (DSB) response at ALT telomeres triggers long-range movement and clustering
between chromosome termini, resulting in homology-directed telomere synthesis. Damaged telomeres
initiate increased random surveillance of nuclear space before displaying rapid directional movement and
association with recipient telomeres over micron-range distances. This phenomenon required Rad51 and
the Hop2-Mnd1 heterodimer, which are essential for homologous chromosome synapsis during meiosis.
Recruitment of Rad51 and Hop2 to damaged telomeres was dependent on ATR and Chk1 signaling.
These findings implicate a specialized homology searching mechanism in ALT-dependent telomere
maintenance and provide a molecular basis underlying the preference for recombination between
nonsister telomeres during ALT.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Cell & Molecular Biology

First Advisor
Roger A. Greenberg

Second Advisor
Michael A. Lampson

Keywords
Alternative Lengthening of Telomeres, Homologous recombination

Subject Categories
Cell Biology | Molecular Biology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/1655

HOMOLOGOUS RECOMBINATION-DIRECTED MECHANISMS OF
ALTERNATIVE LENGTHENING OF TELOMERES
Nam Woo Cho
A DISSERTATION
in
Cell and Molecular Biology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2015

Supervisor of Dissertation
__________________
Roger A. Greenberg, M.D. Ph.D., Associate Professor of Cancer Biology

Graduate Group Chairperson
____________________
Daniel S. Kessler, Ph.D., Associate Professor of Cell and Developmental Biology
Dissertation Committee:
Michael Lampson, Ph.D., Associate Professor of Biology
F. Bradley Johnson, M.D. Ph.D., Associate Professor of Pathology and Laboratory
Medicine
Ronen Marmorstein, Ph.D., Professor of Biochemistry and Biophysics
David Roth, M.D. Ph.D., Professor of Pathology and Laboratory Medicine
Eric Witze, Ph.D., Assistant Professor of Cancer Biology

HOMOLOGOUS RECOMBINATION-DIRECTED MECHANISMS OF
ALTERNATIVE LENGTHENING OF TELOMERES

COPYRIGHT
2015
Nam Woo Cho

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit
http://creativecommons.org/licenses/by-ny-sa/2.0/

Acknowledgement
I would like to extend my sincerest gratitude for those who made the work contained
within this thesis possible. Roger has been the best mentor and a source of constant
learning that I hoped for, walking with me through the entire journey. I also thank Robert,
Niraj, Qinqin, Shane and Karl, the lab members on whom I constantly relied until the
finish line. I thank Mike, who has provided instrumental help and guidance in
visualization and analysis of telomeres. Last but not least, I thank my family and friends.
The very last words of acknowledgement, I saved for my wife Eun Ji for her
understanding and constant love throughout the past few years.

iii

ABSTRACT

HOMOLOGOUS RECOMBINATION-DIRECTED MECHANISMS OF
ALTERNATIVE LENGTHENING OF TELOMERES

Nam Woo Cho
Roger A. Greenberg

Telomere length maintenance is a requisite feature of cellular immortalization and
a hallmark of human cancer. While most human cancers express telomerase activity,
∼10%-15% employ a recombination-dependent telomere maintenance pathway known as
alternative lengthening of telomeres (ALT) that is characterized by multi-telomere
clusters and associated promyelocytic leukemia protein bodies. However, the
mechanisms that govern the lengthening process are poorly understood. Here, we show
that a DNA double-strand break (DSB) response at ALT telomeres triggers long-range
movement and clustering between chromosome termini, resulting in homology-directed
telomere synthesis. Damaged telomeres initiate increased random surveillance of nuclear
space before displaying rapid directional movement and association with recipient
telomeres over micron-range distances. This phenomenon required Rad51 and the Hop2Mnd1 heterodimer, which are essential for homologous chromosome synapsis during
meiosis. Recruitment of Rad51 and Hop2 to damaged telomeres was dependent on ATR
and Chk1 signaling. These findings implicate a specialized homology searching
iv

mechanism in ALT-dependent telomere maintenance and provide a molecular basis
underlying the preference for recombination between nonsister telomeres during ALT.
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CHAPTER 1. Introduction
I. Homologous recombination safeguards genome integrity
Homologous recombination (HR) is an evolutionarily conserved mechanism of
DNA repair that is essential to genome integrity in meiotic and mitotic cells (Mazon et
al., 2010; Moynahan and Jasin, 2010). In particular, this form of DNA repair as a
response to double-strand breaks (DSBs) requires a highly coordinated process that
culminates in an accurate search for and copying of a template DNA with sequence
homology to the broken DNA. One of the critical early steps in this pathway is
nucleolytic resection of DNA ends to generate 3’ single-stranded DNA (ssDNA)
overhangs—this precludes ligation repair by the potentially more mutagenic nonhomologous end-joining (NHEJ) pathway (Symington, 2014). Instead, the ssDNA is
rapidly bound by replication protein A (RPA), which is subsequently replaced by the
Rad51 recombinase. Rad51-coated ssDNA nucleoprotein filament then initiates a search
for homologous sequences (Qi et al., 2015). Successful capture of homology entails base
pairing between invading single stranded DNA with the complementary strand of duplex
DNA, forming a displacement loop (D-loop). Subsequent close association of the
homologous strands (synapsis) and extension by DNA polymerases enables templatedirected DNA repair.
HR-mediated DNA repair mechanisms are largely cell-cycle restricted to S and
G2 phases in mitotic cells in eukaryotes when a sister chromosome is present and
resection-promoting nucleases are more active (Aylon et al., 2004; Huertas et al., 2008;
1

Ira et al., 2004). HR between sister chromatids, rather than homologous chromosomes, is
thought to be the vastly preferred mechanism of HR in mitotic cells (Johnson and Jasin,
2000). Conversely, meiotic HR is not limited to sister chromatid recombination, but
occurs extensively between sequences on homologous chromosomes (Neale and Keeney,
2006). Meiotic recombination involves a lineage-restricted, programmatic form of HR
that is initiated by Spo11 induced DSBs and culminates in synapsis of distant
homologous loci. This process requires Rad51 and Dmc1 as well as the heterodimeric
Hop2-Mnd1 proteins, which promote Rad51- and Dmc1-dependent D-loop formation in
vitro and are epistatic to these RecA homologs during meiosis in yeast and in mammalian
organisms (Bishop, 1994; Chi et al., 2007; Petukhova et al., 2003; Pezza et al., 2007).
Thus, 3-dimensional genome organization during physiologic meiotic recombination is
intimately linked to the repair mechanisms that execute homology searches between nonsister, homologous chromosomes.

II. DNA damage responses at the telomere
A region of the genome that is particularly susceptible to DSB repair mechanisms
is the telomere, a stretch of repetitive homologous DNA sequences (TTAGGG in
vertebrates) that encase each eukaryotic chromosome termini. By virtue of their position
at the end of linear chromosomes, telomeres are potentially recognized as DSBs in the
absence of protective mechanisms such as T-loop formation and presence a multi-protein
complex termed the Shelterin complex (de Lange, 2005; Griffith et al., 1999). Depletion
of one or more of the components of the Shelterin complex predisposes the telomere to
2

specific pathways of DNA repair—NHEJ dependent telomere fusions occur in the
absence of TRF2, for instance, and HR can proceed in the setting of POT1 and Ku70/80
depletion (Sfeir and de Lange, 2012). These Shelterin-deficient or -free telomeres elicit a
robust DNA damage response, and are referred to as “dysfunctional” or “deprotected”
telomeres.
In addition, telomeres can shorten through a process known as the end replication
problem. Due to the inability of the replication machinery to duplicate the region
occupied by the RNA primer on the lagging strand, each cell cycle results in telomere
shortening of about 50-150 base pairs (Martens et al., 2000). Cells that have gone through
a sufficient number of divisions to reach a telomere length of 1-2 kilobases will undergo
senescence. Those that can bypass senescence will most likely die from excessive
damage responses at the telomere, especially during mitosis, in a phase known as crisis
(Hayashi et al., 2015). Thus, telomeres represent a critical location in the genome at
which DNA damage responses are normally appropriately suppressed in order to
safeguard genome integrity and cellular viability.

III. Mechanisms of telomere length maintenance
Cells that continuously divide must avert cell death from telomere shortening and
deprotection. The first mechanism is activation of a reverse transcriptase enzyme
complex known as telomerase, and this occurs in 80-85% of all cancers as well as in
normal germ and stem cells (Greider and Blackburn, 1985). The telomerase enzyme
3

complex uses a non-coding RNA template to processively add telomeric repeats to the
ends of chromosomes. The second mechanism of telomere elongation, occurring in 1015% of human cancers, is termed the Alternative Lengthening of Telomeres (ALT). ALT
is defined as telomere maintenance occurring in the absence of telomerase activity. In
spite of the potential sequelae of aberrant DNA repair reactions at the telomere, cells that
utilize ALT rely on template directed DNA recombination to maintain or lengthen their
telomeres (Dunham et al., 2000). In cancers, telomerase reactivation and ALT each occur
exclusively, even though each mechanism does not suppress the other given that ectopic
expression of hTERT in ALT cells causes both length maintenance mechanisms to
function concurrently (Cerone et al., 2001; Perrem et al., 2001). While anti-telomerase
therapy has been explored, blocking telomerase may result in resistance by upregulation
of ALT activity (Hu et al., 2012), highlighting the importance of understanding
mechanisms in ALT to devise therapeutic approaches.

IV. Hallmarks of ALT
ALT is defined as a mechanism of telomere length maintenance in the absence of
telomerase activity. However, while this definition is one of exclusion, ALT cells
typically demonstrate several hallmarks that positively identify them. The first is the
presence of ALT-associated Promyelocytic leukemia Bodies (APBs), which contain
telomeric DNA within the PML nuclear bodies, along with telomere associated proteins,
DNA repair proteins and chromatin modifying proteins (Yeager et al., 1999). Since DNA
damage repair proteins can be found in PML bodies within non-ALT cells, the presence
4

of telomeric DNA is an exclusive finding in ALT-utilizing cells (Dellaire and BazettJones, 2004).
The presence of APBs correlates with telomere maintenance by ALT. Disruption
of APBs by depletion of PML itself or components of the Mre11/Rad50/Nbs1 (MRN)
complex suppresses telomere length maintenance in ALT cells (Jiang et al., 2005; Zhong
et al., 2007). Furthermore, bromodeoxyuridine (BrdU) accumulation can occur within
APBs in non-S phase cells, indicating that active DNA synthesis is occurring likely as a
part of a DNA repair process as opposed to normal DNA replication (Nabetani et al.,
2004). Importantly, APBs are often strikingly large in size—they can reach sizes up to
several microns—and can contain multiple telomeric material from different
chromosomes as well as extrachromosomal telomeric fragments (Draskovic et al., 2009;
Fasching et al., 2007; Komosa et al., 2015). This is critical for ALT-sustaining
recombination reactions that require a donor and a recipient molecule for the formation of
the D-loop. A high local concentration of DNA repair factors such as RPA32 and Rad51
among a host of other factors likely facilitates recombination.
ALT has also been found to occur in cells lacking APBs (Cerone et al., 2005;
Fasching et al., 2005; Marciniak et al., 2005). Interestingly, some of these cell lines
display arrays of non-telomeric and telomeric amplificons arranged in tandem. This is
analogous to ALT in Saccharomyces cerevisiae, where type I survivors show
ampifications of both telomeric G-rich DNA and subtelomeric Y’ repeat elements, and
type II survivors demonstrate amplifications of only the telomeric G-rich repeats.

5

Mechanisms governing these potential distinct pathways within ALT have not been
investigated in detail.
The other hallmarks of ALT include long and heterogeneous telomere lengths,
telomere sister chromatid exchanges (T-SCEs), and the presence of extrachromosomal
telomeric repeats (ECTRs) such as double-stranded T-circles, largely single stranded ccicrles and linear DNA (Cesare and Griffith, 2004; Henson et al., 2009). These hallmarks
are likely generated from the possible recombination reactions in ALT, which will be
discussed next.

V. Substrates of recombination of ALT telomeres
Due to the repetitive nature of telomeres, recombination at telomeres can
theoretically occur with a variety of substrates and not necessitate a sister strand, which is
normally the vastly preferred substrate for HR (Johnson and Jasin, 2000). These
substrates, which are available even outside of S/G2 phases of the cell cycle, include
telomeres from another chromosome, and ECTRs such as T-circles or C-circles.
Interchromosomal telomeric recombination is evidenced in the initial study which
characterized ALT, demonstrating interchromosomal copying of a telomere-integrated
neomycin resistance tag (Dunham et al., 2000). Furthermore, interchromosomal telomeric
bridges composed of telomeric sequences can be found in metaphase chromosome
spreads of ALT cells (Draskovic et al., 2009). While a rolling-circle amplification
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mechanism such as those demonstrated in yeast is a possibility (Natarajan and
McEachern, 2002), this has not yet been shown in human ALT cells.
Another possible substrate is the sister telomere in the S/G2 phases of the cell
cycle. This activity is suggested by the presence of T-SCEs, which are post-replicative
exchanges in G- or C-rich telomeric sequence resulting in a double signal at a particular
chromosome end (Bailey et al., 2004; Londono-Vallejo et al., 2004). T-SCEs are
generally elevated in ALT cells, although whether these exchange events actually lead to
telomere elongation or merely represent increased recombination activity at ALT
telomeres remains to be sorted out. Furthermore, exchange events can often occur at only
one of the two sister chromatids, whereas a normal exchange between sister chromatids
would result in double signals at both sister chromatids (Conomos et al., 2014). It is
likely that these one-sided exchanges represent recombination with a non-sister substrate.

VI. Current gap in knowledge and potential mechanisms of ALT recombination
A mechanistic understanding of how ALT telomeres recombine is needed. A
plausible model follows a classical model for HR. In this model, the initial step of
recombination involves generation of a 3’ overhang, which if at the end of the
chromosome, is composed of the G-rich sequence. This overhang could be potentially
generated by various nucleases such as Mre11, Exo1, CTIP and Dna2. Alternatively, they
may be unmasked during the normal progression of replication through the telomere.
This overhang should subsequently invade into homologous double-stranded substrate
7

telomere and form a D-loop. It is unclear, however, how this search for homology occurs.
What are the factors that regulate the initial resection and homology search process?
Once the D-loop is formed, several reactions can proceed depending on the nature
of the invading molecule. If both sides of the break contain homology to the intact
substrate, repair could occur by formation of a double Holliday Junction leading to gene
conversion (GC), or by synthesis-dependent strand annealing (SDSA). Gene conversion
is the predominant outcome for breaks at the vast majority of DSBs in somatic cells.
However, if the homology is one-sided or if the break is one-ended, repair can proceed by
a process that may be similar to break-induced replication (BIR) as described in yeast
(McEachern and Haber, 2006). This mechanism is particularly attractive to explain ALT
recombination since the repair would proceed by continuous leading and lagging strand
synthesis for greater than 100 kilobases, resulting in net elongation of the invading strand
(Donnianni and Symington, 2013).
While Rad51 is predicted to be important for the critical strand invasion process,
it is notable that BIR in yeast can occur in a Rad51-dependent and –independent manner
(Malkova et al., 1996). Furthermore, the two types of yeast survivors lacking telomerase
can arise in the setting of Rad51 deletion (type II, telomeric amplification only) and in the
setting of Rad50 deletion (type I, telomeric and subtelomeric amplification). It is unclear
whether these types of pathways exist in human ALT cells and to what extent these
potential mechanisms contribute to ALT telomere maintenance and survival.

8

Lastly, it is unknown what roles the major DNA polymerases play in telomeric
DNA synthesis during ALT recombination. Pol32, a subunit of the delta polymerase
complex, is important for yeast BIR (Lydeard et al., 2007) and its human ortholog PolD3
has been reported to be important for BIR in mammalian cells (Costantino et al., 2014).
Given these findings, it would be instructive to test the role of PolD3 in ALT telomere
synthesis.

9

CHAPTER 2. Interchromosomal Homology Searches Drive Directional
ALT Telomere Movement and Synapsis

I. Introduction
A subset of ALT telomeres coalesces into characteristic ALT-associated PML
Body (APB) structures that display multiple telomeres from different chromosomes in
association with PML (Draskovic et al., 2009; Jegou et al., 2009; Molenaar et al., 2003;
Yeager et al., 1999). These multi-telomere bodies are thought to be sites of homologydirected telomere synthesis (Nabetani et al., 2004). While the nature of the initiating
stimulus for ALT recombination is unclear, one plausible mechanism is that DSB
responses at a subset of ALT telomeres would represent a seminal event that initiates the
search and capture of distant homologous DNA. Pairing and recombination between
telomeres from different chromosomes during ALT would necessitate long range
telomere movement.
Damage dependent increases in local DNA mobility have been documented in
both prokaryotes and eukaryotes, which may suggest that increased movement of broken
chromosomes assists in repair of these loci (Aten et al., 2004; Chen et al., 2013;
Dimitrova et al., 2008; Dion et al., 2012; Krawczyk et al., 2012; Mine-Hattab and
Rothstein, 2012; Roukos et al., 2013). Interestingly, DNA damaging agents increase the
prevalence of APBs in ALT cells, and a subset of ALT telomeres accumulates DNA
repair proteins (Cesare et al., 2009; Fasching et al., 2007). Furthermore, while the
10

majority of telomeres in ALT-positive osteosarcoma U2OS cells display relatively slow
mobility confined to a radius of less than 0.5µm, up to 15% of telomeres show unusually
high mobility (Jegou et al., 2009; Molenaar et al., 2003). Yet, how increased mobility
would facilitate efficient associations between damaged DNA and homologous genomic
regions remains enigmatic, as are molecular events underlying such migration of DNA
across the nucleoplasm lacking canonical structures of cellular transport such as
microtubules.
This section provides direct evidence that telomeric DSB responses drive intertelomere associations in the context of ALT telomeric chromatin. Strikingly, increased
ALT telomere mobility culminated in rapid and directional movement over micron
distances toward a recipient telomere, providing a real-time cellular visualization of
homology search and synapsis in a mammalian cell nucleus. This process required the
HR machinery including Rad51, which could be directly visualized in between
recombining telomeres, representing a putative recombination intermediate. Moreover,
these studies reveal that ALT cells commandeer proteins critical for meiotic
recombination searching mechanisms, providing insights into this specialized form of
HR-driven telomere maintenance.

II. Telomere Double-Strand Breaks Increase the Hallmarks of ALT Recombination
Telomeric chromatin is bound by a set of proteins that recognize double and
single stranded repetitive telomere DNA, termed the Shelterin complex (Cesare and
11

Karlseder, 2012; Palm and de Lange, 2008). Fusion of the telomere repeat binding factor,
TRF1, to the FokI nuclease catalytic domain targets DSBs specifically at telomeres in
both telomerase positive and ALT cells, leading to a robust induction of DSB responses
that extend hundreds of kilobases into subtelomeric chromatin (Tang et al., 2013).
Further characterization of TRF1-FokI expression revealed a DSB response equivalent to
approximately 1-2 Gy ionizing radiation in U2OS cells as assessed by western blot using
antibodies to γH2AX, and phosphorylated-ATM (Figures 1A and B). Notably, Chk2
phosphorylation was not increased to similar levels as phospho-ATM, consistent with
prior reports that telomere damage signals are not efficiently transmitted to some ATM
substrates (Cesare et al., 2013). Despite reduced transmission of ATM phosphorylation to
Chk2, TRF1-FokI expression resulted in a nearly 2-fold increase in cells in the G2 phase
of the cell cycle, consistent with the induction of a G2/M checkpoint (Figure 2A).
Interestingly, TRF1-FokI expression resulted in up to 4-fold increases in average
telomere foci size and reduced numbers of telomeres in each of 4 different ALT positive
cell lines in comparison to cells expressing the nuclease inactive TRF1-FokI D450A
mutant (Figures 1C, 1D and 2B). Telomere foci size increases did not occur in telomerase
negative primary human IMR90 fibroblasts or 4 different telomerase positive cell lines.
Telomere length difference between ALT and telomerase positive cells was not sufficient
to explain foci size increases, as TRF1-FokI expression did not significantly increase
telomere foci size in the telomerase positive HeLa 1.3 cells (Figure 1D), which have a
mean telomere length comparable to ALT cell lines.
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Telomeres within these larger foci in ALT cells contain chromosomally attached
telomeres. This is supported by the observation that metaphase chromosome spreads from
D450A and WT TRF1-FokI were not appreciably different with respect to the percentage
of chromosome ends displaying telomeric signal, and by the presence of subtelomeric
fluorescence in situ hybridization (FISH) signals or subtelomeric lac operator transgene
repeats juxtaposing telomeres in interphase U2OS cells (Shanbhag et al., 2010) (Figures
2C-E). Furthermore, expression of TRF1-FokI increased the percentage of multiple
subtelomeric FISH signals accumulating at a telomere cluster (Figure 1E). These data are
in agreement with previous reports that APB bodies contain chromosomally attached
telomeres (Draskovic et al., 2009). However, they do not exclude the possibility that
extra-chromosomal telomeric repeats (ECTRs), which increase in response to DNA
damage, are also present in these large telomere bodies (Cesare and Griffith, 2004;
Fasching et al., 2007).
These findings suggest that DSB responses at ALT telomeric chromatin provide
the initiating stimulus for telomere clustering. Consistent with this expectation, TRF1FokI expression induced multiple hallmarks of ALT recombination, including significant
increases in telomeres associated with promyelocytic leukemia bodies (APBs) and
telomere associated DNA synthesis as evidenced by incorporation of thymidine analog 5ethynyl-2’-deoxyuridine (edU) in non S-phase cells (Figures 3A-D and Figure 4A).
Similar findings were not detectable in telomerase positive cells. Expression of TRF1FokI also increased c-circle formation, a specific indicator of ALT activity (Figures 4BE) (Henson et al., 2009). Moreover, TRF1-FokI expression increased telomere length
13

heterogeneity by Terminal Restriction Fragment Analysis in 3 different ALT cell lines
(Figure 3E). The increased heterogeneity could result from a combination of factors,
including telomere cutting by TRF1-FokI, as well as ALT recombination associated
length changes and ECTR generation. These telomeres were sensitive to digestion by
Bal-31, an exonuclease that degrades duplex DNA from both 3’ and 5’ ends, indicating
that the longer telomere fragments observable following TRF1-FokI WT expression were
not a consequence of telomere-telomere end joining (Figure 3F).

III. Double-Strand Breaks Initiate Directional ALT Telomere Movement and
Clustering
The presence of intense ALT-like telomere clusters suggests that DSB responses
initiate a homology search process, followed by synapsis and recombination between
distant telomeres. To directly test this hypothesis, we visualized telomere movement
using an inducible mCherryTRF1-FokI fused to a modified estradiol receptor and
destabilization domain, which allowed small molecule induction by administration of 4hydroxytamoxifen and Shield1 ligand (Figure 5A). Following a 1-hour induction period,
TRF1-FokI expressing cells were monitored over the following hour by capturing
confocal z stacks of the entire nucleus every 2 minutes. Telomere foci were tracked in the
z-projected plane, and a registration process (Thevenaz et al., 1998) assisted
normalization for cellular movement.

14

Strikingly, telomeres in TRF1-FokI WT expressing cells demonstrated increased
mobility and an average of 7 telomere-telomere clustering events per hour between foci
separated by up to 5µm (Figures 5B, C, E, F and Movie 1). Telomere clustering and
movement were greatly diminished in the nuclease inactive D450A mutant or in cells
expressing mCherry-TRF1 (Figures 5B-D and Movies 2 and 3). Importantly, less
frequent instances of clustering were observed at mCherry-D450A and TRF1 containing
telomeres, consistent with a previous report of an association of two telomeres in an
unperturbed U2OS cell (Molenaar et al., 2003). TRF1-FokI induced DSBs at ALT
telomeres greatly increase the frequency of telomere associations that normally occur in
these cells.
To determine if DSBs at other regions of the genome in ALT cells would
demonstrate similar movement and clustering as those observed at telomeres, we
monitored targeted and random DSB positions at non-telomeric locations. Fusion of FokI
to the Lac repressor (mCherryLacIFokI) enables efficient visualization of DSB responses
at lac operator repeat sequences integrated into chromosome 1p36 (Shanbhag et al.,
2010). mCherryLacIFokI DSBs did not display large increases in mobility at this locus in
U2OS cells (Figures 6A and B). GFP-53BP1 movement and clustering was also minimal
at most ionizing radiation induced foci during time lapse imaging in U2OS cells (Figure
6C). Conversely, telomeric DSBs moved coordinately with the sub-telomeric LacO locus
in cells expressing both GFP-LacI and mCherryTRF1-FokI (Figure 6D). The lack of
substantial DSB movement at non-telomeric regions of the genome is consistent with
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reports that ALT cells display elevated recombination at telomeres, but not elsewhere in
the genome (Bechter et al., 2003; Dunham et al., 2000).
Importantly, the robust increase in ALT telomere movement allowed a
quantitative analysis of this type of chromatin movement. Telomere tracks were subjected
to a mean squared displacement (MSD) analysis, which plots the average squared
displacements at each time interval, given by equation MSD = <(x(t+Δt)-x(t))2>, where x
is the position of the focus and t is time. The MSD trajectories were then fitted to a single
exponential time dependence diffusion model described by 𝑀𝑆𝐷 =   Γ𝑡 ! where Γ is a
generalized coefficient, and α is a time dependence coefficient which can be used to
determine the type of motion. For α ~ 1, the particle is undergoing normal diffusion, and
α < 1 represents sub-diffusion, also known as anomalous diffusion. Subdiffusive target
searches in cells can result from molecular crowding of the nucleus and cytoplasm
(Guigas and Weiss, 2008). Finally, α ≥ 2 represents an exponential dependence on time
that indicates that the particle is moving in a directed manner, an example of which is
active cellular transport.
A comparison of averaged MSD trajectories for all telomeres in TRF1-FokI WT
or D450A expressing U2OS cells revealed that α = 0.8 for WT and α = 0.7 for D450A,
both characteristic of subdiffusive motion (Figure 5D). The Γ coefficient, which describes
the magnitude of the behavior characterized by α, was greater for WT than for D450A,
with values of 4.7x10-2µm2s-α and 3.3x10-2µm2s-α respectively. Calculation of timedependent diffusion coefficient 𝐷 𝑡 = 𝑀𝑆𝐷/𝑡 = Γ𝑡 !!! showed that the diffusion
coefficient decreases linearly with time with a slope of α-1 when plotted on a log-log
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scale, consistent with subdiffusive motion (Saxton, 2007). For D450A, D(t) at 15 minutes
was 1.4x10-2µm2min-1, consistent with values for normal U2OS telomeres (Molenaar et
al., 2003), and decreased to 0.9x10-2µm2min-1 at the end of the observation period (Figure
6A). For WT, however, D(t) was consistently elevated at 2.6x10-2µm2min-1 and 1.9x102

µm2min-1 at 15 minutes and 60 minutes respectively (Figure 6E). These results indicate

that damaged telomeres move faster and roam a larger nuclear territory.
While all telomeres considered in sum demonstrated diffusive movement, it was
readily apparent from imaging experiments that faster, “incoming” telomeres displayed a
striking long-range directional movement prior to association with a comparatively slowmoving “recipient” telomere (Figure 5B, E and Movie 1). For a quantitative analysis of
this observation, mobility data from telomeres that merged into a recipient telomere was
isolated. The terminal behavior of such telomeres was characterized by MSD analysis of
the last 10 timepoints of each track, with the ultimate timepoint representing the merge
event. The shape of the resulting MSD trajectory suggested an initial, increased diffusive
movement for Δt of up to 10 minutes, followed by a transition to directed movement at
large Δt (Figure 5G) This change in behavior was clearly visualized on a log-log plot.
The α coefficient for the initial portion of the clustering telomere trajectory was 0.9
suggestive of diffusive motion, but between Δt of 12-18 minutes, there was a clear
transition of α to ~ 2.3, indicative of directed movement (Figure 5H).
The average displacement of telomeres during this directed phase was ~1.3µm
with up to 4-5 µm observed for some tracks (Figure 5E, F). Following the clustering
event, the merged telomere foci demonstrated reduced movement (Figure 3I), suggesting
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the searching process that underlies directional movement had concluded. Interestingly,
the less mobile, “recipient” telomere was associated with PML in 85% of clustering
events (Figure 6F). This supports a model in which PML promotes clustering and
recombination of telomeres within APBs (Chung et al., 2011; Draskovic et al., 2009).
To further address whether the driving force behind ALT telomere movement is a
DSB response, spontaneous telomere clustering events in mcherryTRF1 expressing
VA13 cells were quantified with respect to colocalization of GFP-53BP1 as a marker of
DSBs. Greater than 60% of clustering telomeres accumulated GFP-53BP1 prior to
association, while 15% of all telomeres were associated with GFP-53BP1. This indicates
that telomere movement and clustering is closely correlated with a local DNA damage
response (Figure 6G, H).

IV. Homologous Recombination Predominates at ALT Telomere DSBs
The presence of random surveillance followed by directional DSB induced
telomere movement could be a consequence of a homology search and capture between
distant telomeres. Resection of telomeric ends would be a critical determinant of this
pathway choice. RPA localization was assessed at telomeres in cells expressing TRF1FokI in ALT and telomerase positive cells. HeLa 1.3 did not significantly accumulate
RPA at telomeres. Conversely, telomeres in both U2OS and VA13 cells were associated
with RPA at baseline, which further increased in the presence of TRF1-FokI (Figures 7A,
B). Furthermore, expression of TRF1-FokI in U2OS cells resulted in an increase in
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single-stranded telomeres as assessed by electrophoresis and hybridization of telomeric
probes under native conditions (Figure 7C). The increased ssDNA was largely derived
from telomeric overhangs, since the native single stranded telomeric signal was reduced
following treatment with ExoI ssDNA exonuclease (Figure 8A).
Consistent with the observed increases in resection, homologous recombination
proteins BRCA1 and Rad51 were present directly overlying 20-60% of telomeres in ALT
cells and only 5-15% of telomeres in telomerase positive cells after TRF1-FokI DSB
induction (Figures 7D and E). 53BP1 immunofluoresence juxtaposed BRCA1 in both
ALT and telomerase positive cells, consistent with known differences of BRCA1 and
53BP1 chromatin localization adjacent to DSBs (Figures 7D and 8B) (Chapman et al.,
2012; Tang et al., 2013).

V. Rad51 and the HR Machinery Control Directional ALT Telomere Movement and
Clustering
These observations raise the possibility of homology directed telomere
movement, analogous to the reported Rad51 dependency for DSB movement that occurs
during homology searches in yeast (Dion et al., 2012; Kalocsay et al., 2009; Mine-Hattab
and Rothstein, 2012; Oza et al., 2009). To test this hypothesis, TRF1-FokI induced
telomere clustering was quantified following siRNA-targeted depletion of factors
involved in either HR or NHEJ (Figure 9A and 10A). Knockdown of NBS1 and SMC5
reduced telomere clustering in accord with their known involvement in ALT (Potts and
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Yu, 2007; Wu et al., 2003; Zhong et al., 2007). Similar reductions were observed in cells
following knockdown of either BRCA2 or Rad51, but not 53BP1 (Figure 9A) (Jiang et
al., 2007). Interestingly, ALT telomere clustering was independent of BRCA1, consistent
with the HR competency of cells that exhibit extensive resection as a consequence of
53BP1 deficiency (Bouwman et al., 2010; Bunting et al., 2010).
Rad51 molecules nucleate onto RPA-coated ssDNA forming a dynamic
nucleoprotein filament which mediates the presynaptic search for homology (Renkawitz
et al., 2014). Remarkably, expression of GFP-tagged Rad51 in VA13 cells allowed
visualization of GFP-Rad51 filaments that originate specifically at telomeres and
extended to distant telomeres (Figure 9B). Live cell imaging revealed that clustering
could proceed by rapid shortening of the GFP-Rad51 filament with synchronous
directional movement of the incoming telomere (Figures 9C and Movie 4). Of 35
clustering events in cells in which a bridging filament formation was evident, 86%
showed Rad51 localization. Rad51 filament could be directly visualized between
recombining telomeres in approximately 46% of cases in which Rad51 was observable at
telomeres (Figure 10B).
MSD analysis revealed that Rad51 knockdown restricted telomere mobility as
well as telomere clustering events that occur as a result of directed movement (Figures
9D, E and Movies 5 and 6). Interestingly, telomere clustering was decreased by
expression of an ATPase defective dominant negative mutant of Rad51, K133R, which
inhibits HR in mouse cells and has been reported to lock Rad51 filaments into an
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extended conformation that cannot transition to a compressed filament (Figure 10C)
(Robertson et al., 2009; Stark et al., 2002).

V. Hop2-Mnd1 Regulate ALT Telomere Movement and Recombination
TRF1-FokI DSB-induced telomere recombination resembles certain aspects of
recombination between homologous chromosomes during meiosis, which is also initiated
by programmed DSBs and requires RecA homologs Rad51 and Dmc1. The Hop2-Mnd1
heterodimer is necessary for Dmc1 and Rad51 dependent inter-homolog recombination in
vivo during gametogenesis in yeast and in mice (Leu et al., 1998; Petukhova et al., 2003),
and strongly stimulates Rad51 or Dmc1 dependent D-loop formation in vitro (Bugreev et
al., 2014; Chi et al., 2007; Petukhova et al., 2005; Pezza et al., 2007). Moreover, Hop2Mnd1 or Dmc1 mutant yeast and mice display epistasis with respect to meiotic
chromosome inter-homolog synapsis. Hop2-Mnd1 binds double stranded DNA and
induces rapid condensation of large stretches of DNA in vitro, consistent with its
requirement for homolog synapsis (Pezza et al., 2010).
Hop2 protein was broadly expressed in all 16 different ALT cell lines and in
telomerase positive cancer cell lines tested, with lower levels detected in primary human
fibroblasts (Figures 11A and 12A-C). Endogenous Hop2 localized to approximately 1020% of TRF1-FokI damaged telomeres in VA13 cells and at lower levels in the absence
of TRF1-FokI (Figure 12E, F). GFP-Hop2 foci localized adjacent to telomeres in a subset
of ALT cells and foci formation was completely ablated by an M110P point mutant
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within the Hop2 Leucine Zipper domain (Figures 12G, H). This domain is required for
homolog pairing and recombination, with the Leucine Zipper also being necessary for
Hop2 dependent D-loop formation in vitro (Pezza et al., 2006). Hop2 or Mnd1
knockdown strongly reduced telomere clustering, mobility and directional movement to
levels observed in D450A control cells (Figures 11B-D, 12D and Movie 7). Hop2-Mnd1
depletion did not affect Rad51 localization to damaged telomeres (Figure 12I), in
agreement with established roles for the heterodimer in meiotic inter-homolog pairing but
not Rad51 or Dmc1 recruitment to Spo11 dependent DSBs (Petukhova et al., 2003).
To determine if these results would be recapitulated with respect to telomere
clustering and recombination in ALT cell lines that did not express TRF1-FokI, several
different ALT lines were quantified for spontaneous APB formation following
knockdown of Hop2 or Mnd1 with 5 different targeting siRNAs (Figures 11E, F and
14A, B). Knockdown of either Hop2 or Mnd1 significantly reduced APB formation in
each of these lines. The reduction in APBs could be fully rescued by stable expression of
full length Hop2, which is resistant to a siRNA targeted to the 3’UTR (Figure 11G). To
assess the impact of Hop2-Mnd1 on ALT telomere recombination, telomere chromatid
exchanges were assessed by chromosome orientation-FISH (CO-FISH). Knockdown of
Hop2 or Mnd1 reduced telomere chromatid exchanges by 50% or greater in ALT cells
(Figures 11H, I and 14C). Collectively, these data reveal that the forces driving
directional telomere movement are intimately connected to the mechanism of ALT
telomere recombination based lengthening (Figure 13).
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VII. Discussion
The phenomenon of DSB movement has been described in prokaryotes, yeast and
also in mammalian cells within distinct experimental contexts (Aten et al., 2004;
Dimitrova et al., 2008; Dion et al., 2012; Kalocsay et al., 2009; Lesterlin et al., 2013;
Mine-Hattab and Rothstein, 2012; Oza et al., 2009; Roukos et al., 2013). Telomeres
appear to be a particularly predisposed genomic location to DNA damage induced
mobility increases. Diffusive movement of damaged telomeres in telomerase positive
cells has been reported in several independent studies (Chen et al., 2013; Dimitrova et al.,
2008). Notably, the NHEJ promoting factor 53BP1 was required for movement of
deprotected mouse telomeres. However, TRF1-FokI induced directional ALT telomere
mobility required HR factors and was independent of 53BP1, indicative of distinct
mechanisms underlying telomere mobility in each case. Extensive end resection and more
prominent accumulation of HR factors at damaged ALT telomeric chromatin likely
contribute to these differences (Figure 13).
Expression
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TRF1-FokI

enabled

quantitative

characterization

of

an

unanticipated type of chromatin movement. Damaged ALT telomeres initially roamed a
larger nuclear territory at greater velocities than D450A controls, but notably, these
movements culminated in rapid and directional movements of up to 5µm to synapse with
a more stationary recipient telomere. These displacements were also much larger in
magnitude and occurred over a longer time period than those of stochastic unidirectional
“jumps” that could be seen in interphase chromatin (Levi et al., 2005). We note, however,
that pre-selection of clustering tracks in our analysis introduces a bias of describing only
23

highly mobile particles. The analysis of directionality was limited to clustering telomeres,
and this analysis does not preclude the possibility that a proportion of non-clustering
telomeres could move directionally.
To our knowledge, directional ALT telomere movement provides the first
example of real time visualization of homology searches and synapsis in mammalian
cells. Given our data, we favor a model in which Rad51 nucleoprotein filaments
interrogate surrounding nuclear space, leading to homology capture of a non-sister
telomere and subsequent directional movement during synapsis (Figure 13). Interestingly,
dynamic formation of long stretches of prokaryotic RecA coated filaments mediated
rapid associations between DSBs and homologous genomic regions that are separated by
1.3µm (Lesterlin et al., 2013), which are similar to the distances of directional phase
movement we describe for ALT telomeres. The reported structure of ssDNA filaments in
association with RecA reveals an extended conformation that is stretched to ~1.5 fold
longer B-form DNA (Chen et al., 2008). Thus, it is predicted that 1.3µm of nuclear space
connecting non-sister telomeres could theoretically require only ~2.5kb of Rad51 ssDNA
filament for directional movement, which is well within the length possible for ALT
telomeres. Furthermore, as vertebrate telomeres contain extensive regions of homology
consisting of TTAGGG repeats, in effect every chromosome is a “homolog” with respect
to telomere recombination. This feature of primary telomere sequence would be predicted
to increase the probability of recombination between different chromosomes, enabling
successful capturing of distant homology on timescales similar to those observed in much
smaller genomes. It should also be noted that not all recombining telomeres displayed
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Rad51 foci, consistent with the presence of Rad51 independent mechanisms of ALT in
type II survivors of telomerase deficiency in yeast (Chen et al., 2001).
Several obvious parallels exist between meiotic recombination and ALT. Both
processes involve DSB responses to initiate recombination between homologous DNA
sequences on non-sister chromatids. Hop2-Mnd1 uniquely contributes to chromosome
pairing in meiotic recombination and ALT, but is not known to be important for sister
chromatid recombination. Both constituents of this heterodimer are broadly expressed in
ALT and telomerase positive cancers, yet appear to promote telomere recombination only
in cells that use ALT. This may be a consequence of the known interaction of Hop2Mnd1 with Rad51, which did not efficiently nucleate damaged telomeres in telomerase
positive cells. It is also plausible that other factors related to the specific chromatin
environment in ALT cells, such as the absence of ATRX and the association between
ALT and defective histone chaperone activity (Heaphy et al., 2011; Lovejoy et al., 2012;
O'Sullivan et al., 2014; Schwartzentruber et al., 2012), may promote inter-telomere
recombination. Mechanistic studies into this process are warranted, as is the extent to
which ALT recapitulates known mechanisms of meiotic recombination.

VIII. Experimental Procedures
Cell culture
Saos2 cells were grown in McCoy’s 5A medium (Invitrogen) with 15% fetal
bovine serum and 1% penn/strep. DLD cells were grown in RPMI (Invitrogen) with 10%
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calf serum and 1% penn/strep. All other cell lines were grown in DMEM (Invitrogen)
with 10% calf serum and 1% pen/strep. VA13 cell line refers to WI-38 VA-13 subline
2RA.

Plasmids, primers and siRNAs
Flag-TRF1-FokI fusion protein was cloned as previously described (Tang et al.,
2013) into the HFUW lentiviral vector. The coding sequence for mCherry, the modified
estrogen receptor (ER) and destabilization domains (DD) were PCR amplified and cloned
in frame into the N terminus of TRF1-FokI. Rad51 cDNA was cloned into pEGFP-C1.
The N terminal GFP tagged Hop2 expression vector was generated by PCR amplification
and ligation of Hop2 cDNA corresponding to isoform 2 (RefSeq NM_016556.3) from
ProQuest HeLa cDNA Library (Invitrogen). Hop2 M110P mutant was generated by sitedirected mutagenesis.
The following primers were used for qRT-PCR: GAPDH (IDT, PrimeTime assay
Hs.PT.39a.22214836), Hop2/PSMC3IP (IDT, PrimeTime assay Hs.PT.56a.40246325.g),
Mnd1 (IDT, PrimeTime assay Hs.PT.56a.1133039).
The following siRNA sequences were used:
Luciferase, 5’-GCCAUUCUAUCCUCUAGAGGAUG-3’
Control, (Qiagen Allstars)
Rad51 #1, 5’-UGUAGCAUAUGCUCGAGCG-3’
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Rad51 #2, 5’-CCAGAUCUGUCAUACGCUA-3’
Rad51 #3, 5’-UGGAGGGCUGACAGCUUCC-3’
NBS1 (Santa Cruz)
SMC5, 5’-GAAGCAAGAUGUUAUAGAA-3’
53BP1, 5’-UAUUACCGUCUCCUCGUUC-3’
CTIP, 5’-ACACACUCAUGGUGAUAAA-3’
BRCA1, 5’-AGAUAGUUCUACCAGUAAA-3’
BRCA2, 5’-GAAGAAUGCAGGUUUAAU-3’
Hop2 #1, 5’-GCAGCUACCAAUCAUGUGA-3’
Hop2 #2, 5’-AAGAGAAGAUGUACGGCAA-3’
Hop2 #3, 5’-UCUGCUUAAAGGUGAAAGUAGCAGG-3’
Hop2 #4, 5’-UAAAUGUUAACCUCAAGCUACUGCA-3’
Mnd1 #1, 5’-GCUAACAGAUGGACUGAUA-3’

All siRNAs were transfected at 20nM, except for double transfections where each siRNA
concentration was at 10nM, using Lipofectamine RNAiMAX (Invitrogen).
For Hop2 Mnd1 knockdown for APB quantification, knockdown was performed in series
on day 1 and day 4 and cells were fixed on day 7.

Antibodies
The following antibodies were used: anti-53BP1 (rabbit, Novus), anti-BRCA1 D9
(mouse, Santa Cruz), anti-γH2AX JBW301 (mouse, Millipore), anti-H2AX (rabbit,
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Bethyl), anti-phosphoATM Ser-1981 (mouse, ECM Biosciences), anti-phosphoChk2 Thr68 (Rabbit, Cell Signaling), anti-Flag M2 (mouse, Sigma), anti-PML (mouse, Santa
Cruz), anti-Rad51 H-92 (mouse, Santa Cruz), anti-Hop2/PSMC3IP (rabbit, ProteinTech
11339-1-AP; rabbit, Novus NBP1-92301), anti-RPA2 (9H8, mouse, Novus).

Transfections and lentiviral transductions
Transient plasmid transfections were carried out with LipoD293 (Signagen), and siRNA
transfections with Lipofectamine RNAiMax (Invitrogen) according to manufacturer’s
instructions. Concentrated TRF1-FokI lentivirus with polybrene (8ug/ml) diluted in
media was added to cells at a minimum titer resulting in greater than 90% expression at
24 hours by immunofluorescence. Analyses were performed 16 hours after transfection of
plasmids, and 48-72 hours after siRNA transfection. Analyses were performed 24 hours
after transduction of cells with Flag-TRF1-FokI lentivirus.

Western blot
Cells were collected and lysed in RIPA buffer or for histone fractions, acid extracted.
Proteins were resolved on a 4-12% bis-tris gel (Invitrogen). Transferred membranes were
blocked in 5% milk and incubated with primary antibody overnight. For western blot
following TRF1-FokI expression, cells were collected 24 hours after addition of
lentivirus. Cells were collected 72 hours following siRNA transfections.
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Immunofluorescence, IF-PNA FISH and subtelomeric FISH
For anti-Hop2 immunofluorescence, permeabilized coverslips were blocked with 10%
goat serum for 30 minutes at 37°C, followed by incubation with primary antibody for 16h
at 37°C. Coverslips were washed and incubated with appropriate secondary antibody for
20 minutes at 37°C, then mounted onto glass slides using Vectashield mounting medium
with DAPI (Vector Labs).

edU fluorescence assay
16 hours after cells were transfected with mCherry-ER-DD-TRF1FokI, media was
changed to contain 10µM (final) edU. Cells were pre-incubated for 2 hours then Shield1
and 4-OHT were added to the media to induce TRF1FokI for 2 hours. Cells were fixed
and edU was labeled with Alexa488 using Click-iT chemistry (Invitrogen).

Pulsed field gel electrophoresis and in-gel hybridization
Genomic DNA was purified using the Masterpure DNA Purification Kit (Epicentre) per
manufacturer’s instructions. 15ug of purified DNA was digested using AluI and MboI,
and resolved on a 1% PFGE agarose gel (Biorad) in 0.5X TBE buffer using the CHEFDRII system (Biorad) at 6V/cm; initial switch time 5, final switch time 5 for 10-16h.
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Following electrophoresis, the gel was dried at 50ºC for 3h and processed for native or
denaturing probe hybridization. For native hybridization, the dried gel was incubated
with p32 end labeled (TTAGGG)6 oligo probe at 42º for 16h in Church buffer, washed 4
times in 4X SSC and exposed onto a storage phosphor screen (GE Healthcare) and
scanned using STORM 860 with ImageQuant (Molecular Dynamics). For denaturing
hybridization, the gel was denatured in 0.5N NaOH/1.5M NaCl, neutralized and
incubated with p32 end labeled (TTAGGG)6 oligo probe as above.

Nuclease digestion of genomic DNA
For Bal31 digestion, purified genomic DNA (5ug) was incubated with Bal31 (2
units per reaction, TaKaRa/Clontech) in buffer provided by manufacturer for various
timepoints at 30ºC, followed by inactivation in 20mM EDTA at 65ºC for 10 minutes. The
Bal31 digested DNA was then purified by phenol-chloroform extraction and resolved by
PFGE as above. For Exo1, purified genomic DNA (10ug) was incubated with Exo1 for
16h at 37ºC, purified with phenol-chloroform extraction and resolved by PFGE.

C-circle Assay
Purified genomic DNA was digested using AluI and MboI (New England
Biolabs). 15ng or 30ng of DNA was diluted to 10ul, then combined with 10ul of 0.2
mg/ml BSA, 0.1% Tween, 1mM each dNTP without dCTP, 1x φ29 Buffer (NEB) and
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7.5U φ29 DNA polymerase (NEB). Samples were incubated for 8 hours at 30°C then the
polymerase was inactivated for 20 minutes at 65°C. Samples were diluted with 2x SSC to
60ul, then dot-blotted onto Hybond N+ membrane (GE Healthcare). After UV
crosslinking, the membrane was hybridized with p32 labeled (CCCTAA)6 oligo at 37°C
in Church buffer for 16h. Membrane was exposed onto a storage phosphor screen (GE
Healthcare) and scanned using STORM 860 with ImageQuant (Molecular Dynamics).

Chromosome orientation FISH (CO-FISH)
Telomeric CO-FISH can be used to assess the level of postreplicative exchanges
involving a telomere and another TTAGGG repeat sequence, and has been described in
detail previously(Bailey et al., 2004; Londono-Vallejo et al., 2004). Briefly, cells were
incubated with BrdU/BrdC (7.5µM, 2.5µM respectively) for 21h (less than one cell
cycle). Mitotic cells were collected after treatment with 0.1ug/ml colcemid for 90
minutes. Subsequently, cells were incubated in 75 mM KCl and fixed on ice with fresh
fixative (3:1 methanol / acetic acid). Fixed cells were dropped onto slides at 42ºC, and
allowed to dry o/n. The slides were treated with 0.5mg/ml RNaseA for 15 minutes at
37ºC, then with 0.5mg/ml Hoechst 33258 for 15 minutes at RT. Slides were exposed to
365nm UV light for 30 minutes to introduce nicks in the BrdU/C incorporated replicated
strands. The nicked strands were digested twice with 10U/ul ExonucleaseIII (Promega) in
buffer supplied by manufacturer at RT for 10 minutes. Ethanol dried slides were stained
with TelC-Cy3 and TelG-Alexa488 PNA probes (Panagene).
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Live cell imaging
Cells were transfected with mCherry-ER-DD-TRF1-FokI 16 hours prior to
induction with 4-OHT and Shield1 ligand for 60 minutes. Confocal images were acquired
under temperature controlled conditions calibrated to 37ºC, using a 100x 1.4 NA
objective on an inverted fluorescence microscope (DM6000, Leica Microsystems)
equipped with an automated XYZ stage (Ludl Electronic Products), a charge-coupled
device camera (QuantEM 512SC, Photometrics), an X-LIGHT Confocal Imager (Crisel
Electrooptical Systems), and a SPECTRA X Light Engine (Lumencor), controlled by
Metamorph Software (MDS Analytical Technologies). Images were collected as z stacks
at 0.6 µm intervals that covered the entire nucleus, at 2-minute intervals for a total of 60
minutes. Images were processed using ImageJ (NIH). Each z stack was projected onto a
single z plane for each timepoint, and then the t stack was registered using StackReg
plugin in ImageJ to normalize for cell movement. Tracking of individual foci was
performed using the TrackMate plugin for ImageJ (Perry N, Tinevez JY and Schindelin
J). The Mean Square Displacement (MSD) values were calculated using MSD =
<(x(t+Δt)-x(t))2>, where x is the position of the telomere and t is time in minutes.
Resulting data were analyzed and visualized in MATLAB (MathWorks) using the class
@msdanalyzer (written by JY Tinevez, Institute Pasteur). The error bars for each data
point represent the weighted s.e.m. where weights are set to be the number of points
averaged to generate the MSD value at the given delay.
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The MSD trajectories were fitted to a single exponential diffusion model
described by 𝑀𝑆𝐷 =   Γ𝑡 ! where Γ is a generalized coefficient, and α is a time
dependence coefficient. The fitting was performed using least-squares fitting in
GraphPad Prism.
Calculation of the time dependent diffusion coefficient was performed by
calculating 𝐷 𝑡 = 𝑀𝑆𝐷/𝑡 = Γ𝑡 !!! (Saxton, 2007).

For particles undergoing

anomalous/subdiffusion, D(t) decreases linearly with time with a slope of α-1when
plotted on a log-log scale.
For analysis of clustering telomeres as in Figure 3G, H, telomere tracks were preselected for those that displayed clustering during the course of imaging. Telomeres that
clustered during the final 2/3 of the movie were selected to ensure enough datapoints for
movement preceding the association event. Then, the last 10 time points for each of these
tracks were used for analysis (last 10 points prior to the joining event). For the analysis of
incoming and recipient telomeres vs. post merge as in Figure 3I, clustering events that
occurred during the middle 1/3 of the movie were analyzed.

Analysis of telomere foci size and clustering
For measurements of telomeric foci size, ImageJ (NIH) was used to apply a
constant threshold to images and subsequent binarization. Foci sizes were measured as
square pixels for each telomeric focus within a nucleus and the average size was
calculated for each nucleus analyzed. For analysis of clustering following siRNA
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transfection, a cluster was defined as a telomeric focus equal to or greater than four-fold
the area as based on the radius, compared to the average size of undamaged telomeres.

Statistics
Unpaired t tests were used to generate two-tailed p values.

34

CHAPTER 3. Regulation of ALT telomere recombination by the ATRChk1 kinase pathway
I. Introduction
A network of signaling pathways ensure proper coordination of the complex
sequence of molecular reactions that are required for completion of DNA repair. Doublestrand breaks will activate ataxia-telangiectasia mutated (ATM) kinase. If the DSB is
further resected to reveal single-stranded DNA onto which RPA rapidly binds, this
structure recruits and activates ataxia-telangiectasia mutated and Rad3-related (ATR)
kinase (Ball et al., 2005). Importantly, ATR is also activated during normal replication
when ssDNA is exposed and ensures proper progression of the replication fork especially
during periods of replication stress (Flynn and Zou, 2011). Downstream of ATM and
ATR kinase activation, Chk2 and Chk1 kinases are phosphorylated respectively (Falck et
al., 2001; Liu et al., 2000). Subsequent phosphorylation-mediated inhibition of
Cdc25A/B/C phosphatases results in inhibition of cyclin-dependent kinases (CDKs),
leading to cell cycle arrest. This temporary block allows sufficient time for completion of
DNA repair.
The ATR-Chk1 pathway is critical for protection during replication stress both
locally and globally. At the stalled replication fork, ATR stabilizes the structure of the
fork and prevents collapse of the fork (Cobb et al., 2003; Lucca et al., 2004). In the
absence of ATR, collapsed forks could degenerate into DSBs by structure-specific
nucleases such as Mus81, posing a particular threat to cellular viability (Doe et al., 2002).
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ATR also phosphorylates Chk1, which diffuses globally throughout the nucleus to
suppress new origin firing (Shechter et al., 2004; Sorensen and Syljuasen, 2012).
Inhibition of ATR or Chk1 results in deregulated origin firing and generation of DSBs
globally from collapsed forks, leading to irreversible catastrophe and cell death (Buisson
et al., 2015; Toledo et al., 2013).
It was recently shown that ALT activity is disrupted upon ATR inhibition and that
ALT positive cells are selectively killed by ATR inhibition (Flynn et al., 2015). RPA
coated ssDNA telomeres, characteristic of ALT cells, likely serves as a substrate to
activate ATR. However, it is unclear how ATR would regulate ALT activity. One
possibility is a direct effect of ATR-mediated phosphorylation on proteins mediating
ALT recombination. Alternatively, ATR inhibition may exert its effects through
disruption of replication at telomeres as well as the rest of the genome. In this section, I
show that inhibition of ATR or Chk1 activities disrupt Rad51 and Hop2 localization to
ALT telomeres, and that prevention of excessive replication origin firing and DSB
generation partially alleviates this stress.

II. Inhibition of ATR and Chk1 activity disrupts HR factor localization at ALT
telomeres
To test if ATR or Chk1 activity contributes to ALT telomere recombination by
altering recruitment of HR factors, ALT cells were treated with small molecule inhibitors
of ATR or Chk1 kinases. VE-821, which inhibits ATR with an IC50 of 13nM in vitro,
36

and LY-2603618, which inhibits Chk1 with an IC50 of 7nM, strongly reduced Hop2
localization to telomeres in VA13 cells (Figure 15A, C). Hop2 localization was reduced
to less than 50% by 4 hours of treatment, and continued to decline until 24 hours of
treatment (Figure 15 B, D). CHIR-124, another potent Chk1 inhibitor with an IC50 of
0.3nM, reduced Hop2 colocalization with telomeres similarly to LY-2603618 in VA13
cells (Figure 15F). Reduction of Hop2 at telomeres by ATRi was also apparent in
GM847, another ALT cell line (Figure 15 E). Knockdown of ATR recapitulated the loss
of Hop2 in VA13 cells, while knockdown of ATM only marginally affected Hop2 and
knockdown of RNF168 significantly increased Hop2 localization to telomeres (Figure
15G).
In order to test if localization of other HR factors is affected by ATR and Chk1
inhibition, RPA and Rad51 were visualized at ALT telomeres by immunofluorescence.
Interestingly, RPA32 foci maintained colocalization with telomeres even after treatment
with VE-821 in VA13 cells (Figure 16A, B). U2OS cells expressing TRF1-FokI also
largely retained RPA32 foci after treatment with VE-821 or LY-2603618 (Figure 16E).
On the other hand, inhibition of ATR and Chk1 significantly reduced Rad51 recruitment
to telomeres similarly to Hop2 (Figure 16C, D, F). These results show that ATR or Chk1
inhibition, but not ATM or RNF168 inhibition, specifically perturb Rad51 and Hop2
localization to ALT telomeres while RPA recruitment is unaffected.

III. Inhibition of ATR and Chk1 results in genome-wide DNA fragmentation
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Since ATR inhibition results in replication fork breakage and DSB generation
(Toledo et al., 2013), we tested whether telomeres in ATR or Chk1-inhibited ALT cells
could be fragmented. Indeed, VA13 cells treated for 24h with VE-821 or LY-2603618
revealed numerous nuclei with striking increase in fine telomere PNA signals suggestive
of telomere DNA breakage (Figure 17A). The nature of the fine PNA signal is unlikely to
be from generation of extrachromosomal C-circles, since their abundance is unchanged
with ATRi or Chk1i (Figure 17B). In order to confirm that telomeric DNA is being
fragmented, cells treated with VE-821 or CHIR-124 were embedded in agarose plugs and
subjected to pulsed-field electrophoresis in the absence of liberation of DNA by
enzymatic digestion (Saleh-Gohari et al., 2005). This method allows visualization of
DNA fragments that would otherwise be trapped in or near the plug if they were still part
of the intact chromosomal DNA. Treatment with VE-821 or CHIR-124 resulted in
increases in telomere fragments that were most apparent at 24 hours (Figure 17C-E). To
test if breakage was occurring exclusively at telomeres, fragmentation at non-telomeric
locations was assessed using probes recognizing the Alu repeat sequence. This analysis
revealed that ATRi- or Chk1i-induced breaks are not exclusive to telomeres (Figure 17C,
D). In fact, breaks containing the Alu sequence increased more rapidly than those
containing the telomeric sequence (Figure 17E).
Recent data suggests that generation of DSBs and single stranded DNA from
ATRi and Chk1i occurs during S phase (Buisson et al., 2015; Toledo et al., 2013). To
analyze the relationship between emergence of DNA breaks and cell cycle, SV40transformed ALT cell line derived from primary human fibroblasts, LM216JALT, was
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treated with VE-821 or CHIR-124 and analyzed by flow cytometry for γH2Ax and
propidium iodide (PI) signal (Figure 18A, B). With VE-821 treatment, the percentage of
cells positive for γH2Ax doubles by 8 hours and there is a three-fold increase by 24
hours. For CHIR-124, the percentage of γH2Ax-positive cells increases more rapidly. By
4 hours, there is a four-fold increase and by 24 hours, there is a 10-fold increase in the
percentage of cells that are γH2Ax positive. For both inhibitors, the rise in γH2Ax occurs
mostly in S/G2 populations (Figure 18A, B).
To test whether this increase in γH2Ax was specific for ALT cells, LM216TTEL
cells, which express telomerase and are ALT-negative, were analyzed also by flow
cytometry after treatment with VE-821 and CHIR-124. The percentage of total γH2Ax
positive LM216TTEL cells increased similarly to LM216JALT cells (Figure 18A, B).
Interestingly, in LM216TTEL cells, the increase in γH2Ax occurred not only in S/G2 cells
but also in G1 cells. This is unanticipated and the mechanism for generation of breaks in
the G1 population requires further investigation. Regardless, it can be concluded that the
phenotype of DNA fragmentation following ATR or Chk1 inhibition is not specific to the
ALT status of cells.

IV. Limiting replication-dependent fork breakage partially rescues the loss of
Rad51 and Hop2 from ALT telomeres
Previous studies have reported that DNA fragmentation following ATR or Chk1
inhibition can be suppressed by limiting new origin firing by administration of a CDK39

inhibitor roscovitine and by reducing processing of stalled replication forks by
knockdown of Mus81 nuclease (Buisson et al., 2015; Toledo et al., 2013). Indeed,
treatment of VA13 cells with roscovitine strikingly reduced ATRi and Chk1i-dependent
DNA fragmentation assessed by southern blot (Figure 19A). The percentage of γH2Ax
positive cells also decreased 10-fold by treatment with roscovitine (Figure 19B). One
possibility is that generation of DNA fragments could divert factors such as Hop2 or
Rad51 away from telomeres in a dilution manner since DSBs are prevalent throughout
the nucleus. If so, reduction of DSBs by roscovitine treatment or Mus81 knockdown
should allow Hop2 and Rad51 to return to telomeres. In VA13 cells, treatment with
roscovitine or Mus81 knockdown by siRNA transfection partially rescued Rad51 and
Hop2 localization to telomeres (Figure 19C-F). While roscovitine almost completely
prevented DSB generation by ATRi or Chk1i, the magnitude of rescue of Rad51 or Hop2
was only 30-50%. This strongly suggests that ATR and Chk1 inhibition works through
additional mechanisms to suppress Rad51 or Hop2 localization to telomeres.

V. Abrogation of Hop2 expression by CRISPR/Cas9 disrupts ALT activity
In order to test the effect of complete Hop2 loss from ALT cells, we utilized the
CRISPR/Cas9 system to stop the expression of Hop2 in VA13 cells. Several guide RNAs
targeting exon 1 of Hop2 were each transfected into VA13 cells along with Cas9
expression, and resulting cell populations were analyzed by western blotting (Figure
20A). The guide RNAs demonstrated varying levels of efficiency in terms of reduction in
Hop2 expression. Interestingly, the guide sequence sgHop2-b resulted in an absence of
40

any detectable Hop2 expression by western. This was confirmed by the complete absence
of Hop2 immunofluorescence signal in VA13 cells (Figure 20B). Cells selected for
sgHop2-b expression (VA13 sgHop2) were then analyzed for ALT activity. Compared to
the parental VA13 cells, sgHop2 cells demonstrated a 50% reduction in number of
telomere PNA signals colocalizing with PML (APBs) (Figure 20C, D). Furthermore,
clustering was reduced in sgHop2 cells as assessed by average telomere PNA FISH foci
size (Figure 20E). BrdU incorporation occurring outside of S phase was also reduced,
along with the frequency of telomere exchanges assessed by CO-FISH assay (Figure 20F,
G). The reduction of ~50% in ALT activity is similar to the effect observed by Hop2
knockdown using siRNA.

VI. Discussion
One of the unique characteristics of ALT cells that distinguish them from
telomerase positive cells or non-stem somatic cells is the persistent localization of RPA at
telomeres (O'Sullivan et al., 2014). This substrate is likely recognized by ATR; however,
the events occurring downstream of ATR activation in ALT cells is unclear. Here, we
show that HR factor localization is significantly reduced upon ATR or Chk1 inhibition.
Hop2 and Rad51 were rapidly removed from telomeres within 4 hours of treatment with
ATR or Chk1 inhibitors, while knockdown of ATM or RNF168 did not have the same
effect. Interestingly, RPA localization did not decrease following ATRi or Chk1i,
suggesting that the effect of ATR or Chk1 inhibition on Hop2 and Rad51 localization is
downstream of RPA loading onto telomeres.
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ATR and Chk1 kinases possess an overwhelming number of phosphorylation
substrates that coordinately serve to protect the genome in situations such as replication
stress and fork stalling/collapse. In the absence of the kinases, one of the most striking
phenotypes is the generation of DNA DSBs resulting from unregulated origin firing and
resultant fork collapse. In ALT cells, ATR and Chk1 inhibition results in fragmentation
of telomeric DNA as shown by the appearance of numerous fine telomere PNA FISH
signals and by the increase in mobile DNA fragments during electrophoresis. However,
this fragmentation is not specific to telomeres and occurs throughout the genome,
resulting in large increases in percentage of γH2Ax positive cells. In agreement with
previous reports, this breakage was reversed upon suppression of new origin firing with
roscovitine or conversion of stalled forks into DSBs by Mus81. These findings strongly
support a model in which the ATRi/Chk1i-induced fragments are generated during S and
G2 phases of the cell cycle and are dependent on conversion of replication forks into
DSBs.
We tested the hypothesis that the generation of DNA DSBs upon ATR or Chk1
inhibition contribute to the absence of Hop2 and Rad51 from ALT telomeres. However,
while DSBs and γH2Ax were almost completely reduced, Rad51 and Hop2 localization
to telomeres were only partially rescued. Furthermore, reduction of Rad51 and Hop2
occur rapidly following addition of ATR or Chk1i (Figure 15B, D) whereas
fragmentation is most apparent at 8-24hours of treatment (Figure 17C, D). These findings
suggest that additional mechanisms, such as reduction of direct phosphorylation of Rad51
and/or Hop2, could contribute to their loss from telomeres upon ATRi or Chk1i.
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Lastly, additional experiments are needed to investigate how ATR and Chk1
potentially function uniquely in ALT cells compared to non-ALT cells. When comparing
ALT-positive LM216J cells to ALT-negative but telomerase positive LM216T cells, the
levels of induction of γH2Ax were similar between the two cell lines. One possibility is
that with limiting amounts of HR proteins in the nucleus, the generation of DSBs would
dilutionally draw these factors away from ALT telomeres, causing dysfunction. Whether
ATR or Chk1 inhibition would affect ALT telomeres uniquely in this way remains to be
tested.

VII. Experimental Procedures
CRISPR/Cas9 Cell line generation
The following primers were used as guide RNA sequences.
sgHop2-a: GCCGGACGTTGTAGTTGCTCG
sgHop2-b: GCGGGAAAGGCGATGAGTAA
sgHop2-c: GCGGGAGGTAACGGCGCCGT
sgHop2-d: GAGTAGATTCACCCGTTGTC
sgHop2-e: GACCCATGAGAGCCCGACAAC
To generate the cell lines, cells were first transduced with and selected for
blasticidin resistance using lentivirus generated from lentiCas9-Blast plasmid (Sanjana et
43

al., 2014). Cells were then transduced with and selected for puromycin resistance using
lentivirus generated from lentiGuide-Puro plasmids containing the guide RNA sequences
targeting Hop2. Expression of Hop2 was assayed by Western blot 7 days after guide
RNA transduction.

Chemical reagents
VE-821 (Selleck Chemicals) was used at a final concentration of 5uM. CHIR-124
(Selleck Chemicals) was used at a final concentration of 100mM. LY-2603618 (Selleck
Chemicals) was used at a final concentration of 1uM. Roscovitine (Sigma) was used at a
final concentration of 10uM.

DNA Fragmentation Assay
1 million cells were collected by trypsinization and embedded in 1% low melting
point agarose plugs. Plugs were digested overnight in proteinase K digestion buffer
(100mM EDTA pH 8.0, 0.2% sodium deoxycholate, 1% sodium lauryl sarcosine, 1mg/ml
proteinase K) at 50ͦC. After washing in TE, DNA in digested plugs was resolved on a 1%
PFGE agarose gel (Biorad) in 0.5X TBE buffer using the CHEF-DRII system (Biorad) at
6V/cm; initial switch time 5, final switch time 5 for 16h. Following electrophoresis, the
gel was dried at 50ºC and processed for denaturing probe hybridization. The dried gel
was denatured in 0.5N NaOH/1.5M NaCl, neutralized and incubated with p32 end
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labeled (TTAGGG)6 oligo probe overnight. The washed gel was exposed onto a storage
phosphor screen (GE Healthcare) and scanned using STORM 860 with ImageQuant
(Molecular Dynamics).

Flow cytometry
Cells were collected by trypsinization, washed in ice cold PBS and fixed in 70%
ethanol. Permeabilized cells were stained with FITC-conjugated anti- γH2Ax antibody
(Millipore) and with propidium iodide. Cells were analyzed on BD FACSCALIBUR and
data was analyzed using FlowJo software.
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Chapter 4. Conclusions and Future Directions
The scope of the present thesis was to investigate the mechanisms of telomere
recombination in alternative lengthening of telomeres. Understanding the mechanisms
driving ALT is of important therapeutic significance since all cancers rely on one of two
telomere maintenance mechanisms. While numerous therapeutic approaches target
telomerase in an effort to treat ~85% of cancers that overexpress the enzyme, there are no
available treatments for ALT-utilizing cancers, partly due to lack of a mechanistic
understanding of ALT recombination. Major gaps in knowledge exist in terms of the
initiating events leading to ALT, the nature of the substrates for recombination, the
choice of recombination pathways, the composition of the recombination machinery and
the mechanism for DNA synthesis during repair. The present thesis contributes to a
model for ALT recombination that initiates from a DSB response-driven HR reaction.
However, additional studies are required to further probe the linearity of this model by
testing for other parallel recombination mechanisms that may coexist in ALT, and to
understand how the actual DNA synthesis and elongation occurs to ensure survival of
ALT cancers.
Generation of the TRF1-FokI system allowed coordinated induction of ALT
activity and thus enabled a direct view of the initiating events during ALT telomere
recombination. TRF1-FokI expression increased ALT activity, measured by levels of
APB formation, C-circle generation, telomere heterogeneity and new DNA synthesis.
Importantly, one of the most striking phenotypes of TRF1-FokI expression was a rapid
induction of large clusters of telomeres that are found in varying sizes and numbers in
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different ALT cell lines. Telomere foci sizes in U2OS cells are smaller than other cell
lines at baseline, and this allowed us to visualize the formation of large telomere clusters.
Visualization of telomeres in live cells by expression of mCherry-tagged TRF1FokI revealed rapid telomeric clustering events that occurred within 1-2 hours of TRF1FokI induction by Shield1 and 4-OHT. Similar clustering events were observed much
more rarely in TRF1-FokI D450A mutant expressing cells in which no DNA cleavage
occurs. Telomeres traversed between 1-5um in nuclear distance to merge with a recipient
telomere. Instead of moving randomly prior to collision with a second telomere, telomere
foci moved directionally toward the recipient telomere, suggesting that an active process
could be enforcing the merger of two foci.
We had noted that the chromatin state at ALT telomeres favors accumulation of
HR factors instead of NHEJ. RPA normally colocalizes with ALT telomeres, which also
accumulate recombination-promoting proteins such as BRCA1 while NHEJ-promoting
53BP1 remains at the periphery of telomere foci. Furthermore, telomere overhangs that
are substrates for initiation of HR are prominent in ALT cells and are increased with
TRF1-FokI. Thus, we tested whether Rad51, a recombinase that replaces RPA on ssDNA
overhangs and is critical for homology search and D-loop formation, is required for ALT
telomere movement. Clustering events and telomere movement were reduced upon
knockdown of Rad51 by siRNA. Strikingly, GFP-Rad51 filaments could be directly
visualized between merging telomeres, suggesting that Rad51-ssDNA nucleoprotein
filament could directly bridge two recombining telomeres in order to facilitate their
juxtaposition and synapsis.
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The fact that ALT telomeres traverse several microns within the nucleus to merge
with another telomere suggests that these recombination events are occurring between
non-sister telomeres. This is a unique situation since the vast majority of HR reactions in
somatic cells occur between homologous sequences on sister chromatids. On the other
hand, a situation in which interchromosomal recombination preferentially occurs is
during meiotic recombination. Crossover recombination occurs upon programmed DSB
generation and juxtaposition of homologous chromosomes that are microns away in the
nucleus. Interestingly, meiotic recombination requires a critical factor called
Homologous-Pairing 2 (Hop2), which functions together with Mnd1 and the meiotic
recombinase DMC1 to complete chromosome pairing (Leu et al., 1998; Pezza et al.,
2007). Hop2 and Mnd1 were broadly expressed in all cancer cell lines tested, but its
expression was limited in mortal fibroblast cell lines. Importantly, knockdown of Hop2
and Mnd1 reduced ALT telomere clustering and movement following TRF1-FokI
expression. Furthermore, Knockdown of these proteins resulted in disruption of ALT
activity by reducing APB formation and telomere exchanges in ALT cells even in the
absence of TRF1-FokI.
These data show that ALT telomere recombination is intimately linked to the
homologous recombination machinery and that a DSB response initiates a homology
search requiring Rad51 and Hop2-Mnd1. A model for ALT could be proposed based on
these findings: DSB responses at ALT telomeres triggers recruitment of HR factors that
carry out a search for a homologous substrate, followed by synapsis, D-loop formation
and DNA synthesis to complete the repair process. Questions remain as to how the HR
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factor recruitment process is regulated, and how DNA synthesis proceeds following Dloop formation.
RPA-coated single stranded DNA is a substrate readily recognized by ATR
kinase, which signals downstream to a number of different substrates such as Chk1. It is
reasonable to hypothesize that RPA-coated single stranded telomeres, which are abundant
in ALT cells, could activate ATR in order to trigger the recombination pathway. During
normal recombination, RPA-coated single stranded DNA that becomes exposed recruits
ATR to initiate a HR-dependent repair pathway that restores the replication fork. A
similar process could take place during periods of replication stress at ALT telomeres
occurring in the absence of ATRX (Clynes et al., 2015).
Inhibition of ATR or Chk1 with small molecule inhibitors resulted in a striking
reduction of Rad51 and Hop2 localization to ALT telomeres within 4 hours of treatment.
On the other hand, recruitment of RPA to telomeres did not decrease significantly upon
ATRi or Chk1i, which is consistent with the expectation that inhibition of ATR would
not affect the nature of the substrate that it recognizes. We hypothesized that the
reduction in Rad51 and Hop2 could be directly due to the loss of their recruitment by
ATR and Chk1, or indirectly due to the effect of ATRi and Chk1i on ALT cells. Since a
prominent effect of ATRi and Chk1i is fragmentation of the genome from collapsed
replication forks, we asked whether this phenomenon contributes to the loss of Rad51 and
Hop2 from ALT telomeres by creating a catastrophic number of DSBs elsewhere in the
genome that deplete the available pool of HR factors.
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ATRi and Chk1i caused significant fragmentation of ALT telomeres, as
evidenced by increased signal upon electrophoresis of free DNA fragments. The DSB
generation was not specific to telomeres, but instead was global since breaks in Alu
sequences, interspersed throughout the genome, were more prominent than telomeric
breaks. These breaks could readily be detected using γH2Ax staining of treated cells. As
reported previously, the DSB generation from ATRi or Chk1i could be limited using
roscovitine, a CDK inhibitor, or siMus81. We then analyzed whether elimination of
DSBs during ATRi or Chk1i could rescue Rad51 and Hop2 loss from telomeres. Upon
treatment with roscovitine or knockdown of Mus81, Rad51 and Hop2 localization was
partially rescued even though roscovitine almost completely limited DSB and γH2Ax
generation. These results indicate that while genome-wide breaks following ATRi and
Chk1i is a prominent feature that leads to cell death in treated cells, they do not wholly
account for the loss of Rad51 and Hop2 from ALT telomeres. Further experiments are
needed in order to understand potential mechanisms of ATR and Chk1-mediated
recruitment of HR factors in ALT.
In sum, these data are consistent with a DSB-initiated HR-driven mechanism for
ALT telomere recombination. However, several aspects of the model still remain unclear.
How does the terminal process of DNA synthesis occur and which DNA polymerases are
critical? Are there alternative or co-existing pathways for recombination in ALT?
A prediction from the proposed model is that ALT recombination events should
culminate in synthesis of new DNA. In mammalian cells, there are 15 characterized DNA
polymerases that could fulfill this role. A minority of these polymerases carries out
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normal replication, while the majority performs various forms of DNA repair. Although
direct evidence of DNA synthesis by these polymerases during repair has been lacking
due to a lack of an appropriate mammalian system in which to study DNA synthesis, the
polymerases that have been implicated in HR or NHEJ include Polβ, Pol ζ, Pol η, Pol θ,
Pol λ and µ. Interestingly, Pol β was required for synapsis during meiosis, functioning at
an early step in the processing of meiotic DSBs (Kidane et al., 2010). Pol η deficiency
results in reduced gene conversion events that occur as a result of HR in chicken DT40
cells. Additionally, Pol η can perform repair synthesis in vitro to extend the end of the 3’
overhang serving as a primer, resulting in second-end capture by Rad52, which is a
critical step in HR repair reactions involving homology on both ends of the broken strand
(McIlwraith and West, 2008).
For ALT telomere synthesis, the putative substrates undergoing recombination
suggest a similar but distinct type of reaction known as break-induced replication (BIR)
may occur. While a DSB within the body of the chromosome contains two broken ends
that need to be repaired, a break at a telomere is a one-ended starting substrate. BIR has
been most extensively studied in eukaryotes in the budding yeast Saccharomyces
cerevisiae. During BIR, the initial steps of 3’ ssDNA overhang generation and invasion
into a region of homology seem to be shared with gene conversion events that occur with
homology on both ends of the break. However, upon formation of the D-loop, conversion
to a replication fork-like structure occurs involving leading- and lagging-strand synthesis.
In yeast, the requirements for replication at this stage are distinct from those of normal Sphase replication where Pol ε performs leading strand copying while Pol δ copies the
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lagging strand. Pol32, a component of the Pol δ complex, along with Pol α-Primase
complex is required for yeast BIR while Pol ε is dispensable for the initial steps of
synthesis (Lydeard et al., 2007). The mammalian homolog of Pol32 is PolD3, which was
recently implicated in allowing survival of cells undergoing replication stress upon cyclin
E overexpression by a BIR-like mechanism (Costantino et al., 2014). These data suggest
that the mammalian Pol α, δ and ε complexes are prime candidates for interrogation in
ALT telomere synthesis which potentially proceeds by BIR as it does in yeast
telomerase-null survivors (McEachern and Haber, 2006). We have preliminary data using
TRF1-FokI as a system to probe for newly synthesized DNA at the telomeres. These
assays should prove useful for understanding the requirements of mammalian DNA
polymerases for ALT telomere recombination and synthesis.
A second interesting question that arises from comparison to ALT in yeast is
whether different mechanisms of ALT recombination could exist. In S. cerevisiae, two
pathways allow “survivors” to form in the absence of telomerase, both of which require
Rad52 but only one of which requires Rad51 (Louis et al., 1994; Lundblad and
Blackburn, 1993; Teng and Zakian, 1999). The first pathway (Type I) is characteristic for
amplification of subtelomeric Y’ elements along with telomeric repeats, and is dependent
on Rad51 along with Rad52 and Rad54 (Le et al., 1999; Teng and Zakian, 1999). The
second pathway (Type II) is notable for long and heterogeneous amplifications involving
only telomeric repeats, and does not require Rad51 but relies on Rad52, the MRX
complex and Rad59 (Lundblad and Blackburn, 1993).
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We have observed that knockdown of Rad51 and Hop2 proteins resulted in ALT
activity decreases of about 50% across the different assays that were employed including
APB formation and telomere exchanges. These observations leave open the possibility
that complementary mechanisms could replace the functions of Rad51in mammalian
cells. This idea is supported by the observation that yeast BIR can also proceed in Rad51dependent and –independent manners (Ira and Haber, 2002; Malkova et al., 2001; Signon
et al., 2001). A prediction of this model would be that concurrent inhibition of
complementary pathways on which human ALT cells depend would be more effective in
reducing ALT activity and inducing cell death. The initial candidates to test in this
context are human Rad52, the Mre11-Rad50-Nbs1 (MRN) complex, BLM and WRN
helicases and ATR (Cohen and Sinclair, 2001; Huang et al., 2001; Johnson et al., 2001;
Signon et al., 2001; Tsai et al., 2002).
Understanding the mechanisms in play during ALT telomere recombination has
become an exciting field that provides a system for interrogating poorly characterized
repair pathways in mammalian cells and offers an opportunity to develop rational
strategies for targeting ALT-positive tumors. I hope that the work presented in this thesis
will be useful for subsequent studies of ALT telomeres and homologous recombination.
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Figure 1
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Figure 1. TRF1-FokI DSBs Promote Telomeric Clustering in ALT Cells
(A) Schematic of telomere-specific DSB induction by the TRF1-FokI fusion protein.
(B) Comparison of DSB responses in U2OS cells between TRF1-FokI expression and
escalating doses of IR. Immunoblot (IB) was performed at 30 minutes following
irradiation. Mock indicates mock viral transduction; D450A and WT indicate nuclease
inactive and wild type TRF1-FokI, respectively.
(C) Representative immuno-FISH images of TRF1-FokI (Flag) WT or D450A
colocalized with telomeres (PNA) in ALT positive and negative cells.
(D) Average telomere foci size per nucleus after TRF1-FokI expression was calculated
using ImageJ. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 3. *
p<0.05, n.s. p>0.05.
(E) FISH was performed in cells expressing TRF1-FokI WT or D450A using a
combination of chromosome-specific subtelomeric (subtel) probes and PNA. Percentages
of colocalized subtel-PNA foci that contained one, two or three subtelomeric signals were
quantified from >100 cells in n =2.
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Figure 2
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Figure 2. TRF1-FokI Induced Clustering Occurs Specifically in ALT Cells
(A) Cells that were mock treated or transduced with TRF1-FokI WT or D450A virus
were incubated with BrdU for 1 hour then analyzed by flow cytometry.
(B) Representative immunofluorescence images for two additional ALT and telomerase
positive cell lines after expression of TRF1-FokI WT or nuclease inactive D450A mutant.
(C) Fraction of PNA signal positive telomeres per total ends for each metaphase was
quantified after TRF1-FokI expression. Mean of >40 metaphases were calculated from 2
independent experiments.
(D) GFP-LacI and TRF1-FokI were co-expressed in U2OS reporter cell line with LacO
repeat sites integrated into a subtelomeric genomic locus at 1p36.
(E) FISH was performed in cells expressing TRF1-FokI WT or D450A, using the
indicated chromosome-specific subtelomeric probes and PNA. Percentages indicate
percentage of subtelomeric signals that are adjacent to a telomeric signal, quantified from
>100 cells in two independent experiments.

57

Figure 3
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Figure 3. TRF1-FokI DSBs Promote ALT Activity
(A) Representative PNA/anti-PML immuno-FISH images of cells expressing TRF1-FokI
WT or nuclease inactive D450A mutant.
(B) Number of PML-PNA colocalizations (APBs) per nucleus was quantified in cells
expressing TRF1-FokI WT or D450A. Mean of >100 cells from three replicate
experiments. *** p < 0.005, n.s. p > 0.05.
(C) Representative images of edU positive TRF1-FokI foci in VA13 cells.
(D) Fraction of nuclei with ≥ 3 TRF1-FokI telomere foci colocalizing with edU foci in
non-S-phase cells was quantified after expression of TRF1-FokI as indicated. Mean ±
s.e.m., >50 cells in n = 3. * p<0.05.
(E) Digested genomic DNA from cells expressing TRF1-FokI was resolved by pulsedfield gel electrophoresis (PFGE) and probed for total telomeric DNA.
(F) Digested genomic DNA from U2OS cells expressing TRF1-FokI WT or D450A were
treated with Bal31 nuclease for the indicated durations, resolved by PFGE and probed for
total telomeric DNA.
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Figure 4
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Figure 4. TRF1-FokI DSBs Promote ALT Activity
(A) The percentage of cells with ≥ 3 telomere foci colocalizing with PML was quantified
in the indicated cell lines following TRF1-FokI expression (Mean ± s.e.m., >50 cells in n
= 3. * p<0.05).
(B-C) U2OS cells were transfected with mCherry-TRF1-FokI and induced with Shield1
and 4-OHT for the indicated durations, and c-circle assay was performed using the
indicated amounts of genomic DNA. Mean ± s.e.m., n=4.
(D-E) U2OS cells were transduced with mock, TRF1-FokI D450A or WT virus for 24
hours and c-circle assay was performed using the indicated amounts of genomic DNA.
Mean ± s.e.m., n=2.
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Figure 5. ALT Telomere DSBs Rapidly Associate by Long Range, Directional
Movement
(A) Schematic of time-lapse imaging of telomeres in cells expressing TRF1-FokI. mC,
mCherry; ER, modified estrogen receptor; DD, destabilization domain.
(B) Representative 1-hour traces of mCherryTRF1-FokI D450A or WT foci in U2OS
nuclei. White box indicates region shown in (E).
(C) Quantification of telomere-telomere clustering where merged foci remain
unseparated in 3 or more frames. In red, mean ± s.e.m. Each datapoint represents tracked
nuclei from two independent experiments. *** p<0.0005. TRF1only represents
mCherryTRF1 protein without C-terminal FokI.
(D) Mean squared displacement (MSD) analysis of telomere movement in U2OS cells
expressing mCherryTRF1-FokI D450A or WT. Δt, time interval. Error bars, weighted
s.e.m. and n = >700 tracks in two independent experiments. Fit was determined by a
diffusion model, 𝑀𝑆𝐷 =   Γ𝑡 ! , where α is the time dependence coefficient. α WT = 0.8 and
α D450A = 0.7.
(E) Expanded images of a tracing from (B) highlighting diffusive movement followed by
directed movement toward another telomere. * and bar denotes displacement measured in
(F). Yellow lines indicate the path traveled by the particle during the previous 10 frames.
(F) Quantification of telomere displacement during directed movement (mean ± s.e.m of
tracks from 2 independent experiments; n.s. p>0.05). Directed phase was defined by
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consecutive motion toward the recipient telomere over 3 or more frames until the merge
event.
(G) MSD analysis of clustering telomeres in U2OS cells expressing TRF1-FokI WT (see
text). ΔT=18 represents the point of merge into a recipient telomere. n = 157 tracks from
2 independent experiments. Error bars, weighted s.e.m.
(H) Data from (G) is displayed on a log-log plot. Time dependence coefficient, α, for two
phases of movement is indicated.
(I) MSD analysis of mobility before and after a merge event. Δt=0 represents the point of
merge. Error bars, weighted s.e.m. and n = 46 tracks from two independent experiments.
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Figure 6
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Figure 6. Damage-dependent Chromatin Movement in ALT is Telomere Specific
(A) Schematic of U2OS reporter cell line containing integrated LacO transgene proximal
to the chromosome 1p telomere.
(B) Montage of live-cell images captured after induction of mCherry-LacI-FokI DSBs in
the reporter cell line.
(C) Montage of live cell images in a representative U2OS cell expressing GFP-53BP1.
Cells were treated with 2Gy IR and visualized after one hour. Arrowheads follow three
GFP-53BP1 spots over the course of the experiment.
(D) mCherry-TRF1-FokI and GFP LacI were co-expressed in the U2OS reporter cell line
and visualized with live cell imaging.
(E) Time-dependent diffusion coefficient D(t) = MSD/Δt is plotted on a log-log scale for
telomeres in cells expressing TRF1-FokI WT or D450A.
(F) Telomere clustering events in U2OS cells co-expressing mCherry-TRF1-FokI and
GFP-PML were analyzed with respect to an associated GFP-PML signal.
(G) Live cell images of VA13 cells co-expressing mCherry-TRF1only and GFP-53BP1
were analyzed for telomeres with or without colocalized 53BP1 signal.
(H) Montage of a representative clustering event in experiment in (G).
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Figure 7
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Figure 7. Homologous Recombination Predominates at ALT Telomere DSBs
(A) Representative immunofluorescence images of RPA2 and mCherry-TRF1-FokI WT
in HeLa1.3 and VA13 cells.
(B) Quantification of RPA-telomere colocalization in ALT cell lines (U2OS and VA13)
and a telomerase positive cell line (HeLa1.3).
(C) Telomeric DNA from U2OS and HeLa1.3 cells expressing TRF1-FokI D450A or WT
was resolved by PFGE, and probed with p32 labeled oligos hybridizing to the G-rich
single-stranded telomeres under native conditions. The gel was denatured and probed
again for total telomeric signal.
(D) Representative immunofluorescence images of Rad51, BRCA1 and 53BP1 and
mCherryTRF1-FokI WT and D450A positive telomeres in U2OS cells.
(E) Colocalization of Rad51 and BRCA1 to mCherryTRF1-FokI WT and D450A positive
telomeres in ALT positive and negative cells. Tel, direct overlying colocalization to
telomeres; Mean + s.e.m., n=2.
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Figure 8. Increased Single-stranded Telomeric Signal is Largely from Telomeric
Overhangs
(A) Digested genomic DNA from U2OS cells expressing TRF1FokI D450A or WT were
treated with Exonuclease I prior to resolution by pulsed-field gel electrophoresis and
hybridization under native and denatured conditions.
(B) Representative triple stained confocal microscopic images of native telomeres in
ALT nuclei that accumulate 53BP1 and BRCA1.
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Figure 9. Rad51 Promotes Diffusive and Directed ALT Telomere Movement
(A) Quantification of TRF1-FokI induced telomere clustering at 72 hours following
transfection of siRNA targeted to the indicated genes. Mean ± s.e.m., n=3. p values refer
to tests between siLuciferase and indicated siRNA. ** p<0.005, n.s., p>0.05. See
Experimental Procedures for analysis of clustering.
(B) Top panels, FISH image of a VA13 cell expressing GFP-Rad51, hybridized with
telomeric PNA probe. Last panel shows an expanded area demarcated by the white box.
Bottom panels, fluorescence image of a VA13 cell co-expressing mCherry-TRF1-FokI
and GFP-Rad51.
(C) Representative montage of a live-cell telomere clustering event in a VA13 cell
expressing mCherry-TRF1-FokI and GFP-Rad51.
(D) MSD analysis of telomere movement after Rad51 knockdown in U2OS cells.
Nuclease inactive D450A is shown for reference. Fit determined by a diffusion model,
𝑀𝑆𝐷 =   Γ𝑡 ! . Error bars, weighted s.e.m. and n > 450 tracks from two independent
experiments.
(E) Number of telomere clustering events that occur per nucleus following directed
movement is quantified after Rad51 knockdown in U2OS cells. Mean ± s.e.m. from two
independent experiments. *** p<0.0005.
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Figure 10. Rad51 Guides ALT Telomere Movement and Clustering
(A) Western blotting was performed in U2OS cells at 72h after knockdown of the
indicated genes by siRNA.
(B) Live cell imaging was performed in VA13 cells co-expressing mCherry-TRF1FokI
and GFP-Rad51. Cells that contained at least one GFP-Rad51 filament in between
telomeres were analyzed for percentages of clustering telomeres that displayed the
following characteristics: (1) colocalization with GFP-Rad51 foci, or (2) connected by a
GFP-Rad51 filament. n = 35 total clustering events analyzed from 4 independent
experiments.
(C) U2OS cells expressing TRF1-FokI WT were transfected with GFP-Rad51 WT or
K133R mutant. Average PNA telomeric foci size per nucleus was calculated from >100
cells from three experiments. Mean ± s.e.m., *** p<0.0005.
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Figure 11. Hop2-Mnd1 Regulate Telomere Clustering and Recombination in ALT
(A) Western blotting was performed in the indicated cell lines using an antibody that
recognizes the endogenous Hop2 protein.
(B) Telomere clustering in U2OS cells expressing TRF1-FokI was quantified as in (5A)
after Hop2-Mnd1 knockdown. Mean ± s.e.m., n = 3. ** p<0.005, *** p<0.0005.
(C-D) Live-cell analysis of telomere movement in U2OS cells expressing mCherryTRF1FokI WT was used to quantify telomere clustering after knockdown with the indicated
siRNAs. D450A is shown for reference. Fit determined by 𝑀𝑆𝐷 =   Γ𝑡 ! . Error bars,
weighted s.e.m. and n > 550 tracks from two independent experiments. ** p<0.005, ***
p<0.0005.
(E) Representative images of telomere colocalization with PML foci in VA13 cells after
control or Hop2 knockdown.
(F) Spontaneous APB formation was assessed in VA13 cells after serial knockdown of
Hop2 or Mnd1 (Extended Experimental Procedures). Mean from >100 cells from 3
experiments.
(G) Spontaneous APB formation was assessed following Hop2 siRNA targeting the 3’
UTR region in parental VA13 cells and in VA13 cells stably expressing Hop2 cDNA.
Mean from >100 cells from 3 experiments.
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(H) Representative examples of telomere exchanges from CO-FISH are shown for cells
with control or Hop2 knockdown (siRNA #1). The arrowhead reveals a T-SCE. Full
images shown in Figure S7C.
(I) Quantification of total number of exchanges from CO-FISH assay after Control, Hop2
or Mnd1 knockdown. >50 metaphases in two independent experiments.
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Figure 12. Hop2-Mnd1 Regulates Telomere Clustering and Recombination in ALT.
(A) Western blotting was performed in the indicated ALT cell lines using an antibody
that recognizes endogenous Hop2 protein.
(B) Quantitative RT-PCR was performed after transfection of the indicated siRNA in
U2OS cells. Mean ± s.e.m., n=2.
(C) Western blotting was performed using the anti-Hop2 antibody after transfection of
the indicated siRNA in U2OS cells. *, nonspecific band seen in longer exposures. White
line is shown to indicate irrelevant lanes between siCTL and siHop2 were removed.
(D) Live-cell analysis of telomere movement in U2OS cells expressing mCherryTRF1FokI WT was used to quantify telomere clustering after knockdown with the indicated
siRNAs. D450A is shown for reference. Nonlinear fit determined by a single exponential
diffusion model, 𝑀𝑆𝐷 =   Γ𝑡 ! . Error bars, weighted s.e.m. and n > 550 tracks from two
independent experiments.
(E) IF was performed in VA13 cells with antibodies to the Flag epitope and to
endogenous Hop2 protein as indicated at 72 hours after indicated siRNAs and 24 hours
after expression of Flag-TRF1FokI.
(F) Endogenous Hop2 localization to telomeres was quantified in VA13 and HeLa 1.3
cells with or without TRF1-FokI expression.
(G) Schematic of Hop2 protein, highlighting its domain structure and the M110 residue
within the Leucine Zipper (LZ) domain.
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(H) GFP-Hop2 localization proximal to TRF1-FokI was assessed in U2OS cells. The
Leucine Zipper domain mutant, M110P abolished GFP-Hop2 colocalization with TRF1FokI.
(I) Flag-TRF1FokI WT was expressed in VA13 cells at 48 hours after transfection with
the indicated siRNA. Immunofluorescence was performed with anti-Flag and anti-Rad51.
Mean ± s.e.m, n = 2; n.s., p>0.05.
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Figure 13

Figure 13. Model for a Specialized Homology Search Mechanism that drives ALT
Telomere Recombination
A specialized homology searching mechanism is required for synapsis between distant
telomeres. Extensive end resection at ALT telomeres facilitates a Rad51 dependent
homology search. Homology capture followed by synapsis and congression of
homologously paired non-sister telomeres would be responsible for directional telomere
movement. This ALT telomere recombination mechanism relies in part on Rad51 and
Hop2-Mnd1 to promote synapsis between non-sister telomeres.
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Figure 14. Hop2-Mnd1 Regulates Telomere Clustering and Recombination in ALT.
(A) Spontaneous APB formation was assessed in ALT cell lines with Hop2-Mnd1
depletion. Positive cells exhibited ≥ 3 colocalized foci. siH+M indicates cotransfection of
siHop2#1 and Mnd1#1. Mean ± s.e.m., n = 3. * p<0.05
(B) Western blotting was performed with antibodies to PML or Hop2 in VA13 cells 72
hours after transfection of indicated siRNAs.
(C) Representative images of CO-FISH experiments after knockdown of Hop2. Examples
of telomere exchanges are highlighted with white arrowheads.
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Figure 15. Hop2 localization to telomeres is disrupted upon ATR or Chk1
inhibition.
(A) Representative PNA/Hop2 immuno-FISH images of VA13 cells treated with or
without ATR inhibitor (VE-821) for 24h prior to fixation. TRF1-FokI virus was added
24h prior to fixation.
(B) Quantification of Hop2-PNA colocalization events in VA13 cells treated with VE821 for the indicated durations prior to fixation. TRF1-FokI virus was added 24h prior to
fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2.
(C) Representative PNA/Hop2 immuno-FISH images of VA13 cells treated with or
without Chk1 inhibitor (LY-2603618) for 24h prior to fixation. TRF1-FokI virus was
added 24h prior to fixation.
(D) Quantification of Hop2-PNA colocalization events in VA13 cells treated with LY2603618 for the indicated durations prior to fixation. TRF1-FokI virus was added 24h
prior to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2.
(E) Quantification of Hop2-PNA colocalization in VA13 and GM847 ALT cells treated
with or without VE-821 for 24h prior to fixation. TRF1-FokI virus was added 24h prior
to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. * p<0.05
(F) Quantification of Hop2-PNA colocalization in VA13 cells treated with or without
Chk1 inhibitor (CHIR-124) for 24h prior to fixation. TRF1-FokI virus was added 24h
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prior to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. **
p<0.005
(G) Quantification of Hop2-PNA colocalization in VA13 cells transfected with the
indicated siRNAs. TRF1-FokI virus was added 24h prior to fixation. Mean ± standard
error of the mean (s.e.m.) for >50 cells in n = 3. *** p<0.0005
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Figure 16. ATR and Chk1 inhibition reduces Rad51, but not RPA, localization to
ALT telomeres.
(A) Quantification of RPA/PNA colocalization events in VA13 cells treated with or
without VE-821 for 24h. Mean ± standard error of the mean (s.e.m.) for >50 cells in n =
3. n.s. p>0.05.
(B) Representative RPA/PNA immuno-FISH images of VA13 cells treated with or
without VE-821 for 24h.
(C) Quantification of Rad51/PNA colocalization events in VA13 cells treated with or
without VE-821 for 24h. Mean ± standard error of the mean (s.e.m.) for >50 cells in n =
3. n.s. p>0.05.
(D) Representative Rad51/PNA immuno-FISH images of VA13 cells treated with or
without VE-821 for 24h.
(E) Quantification of RPA/PNA colocalization events in U2OS cells treated with or
without VE-821 for 24h. TRF1-FokI virus was added 24h prior to fixation.
(F) Quantification of Rad51/PNA colocalization events in U2OS cells treated with or
without VE-821 for 24h. TRF1-FokI virus was added 24h prior to fixation.
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Figure 17. Genome fragmentation occurs following ATR or Chk1 inhibition.
(A) Representative PNA FISH images of VA13 cells treated with ATRi (VE-821) or
Chk1i (LY-2603618).
(B) C-circle assay was performed on genomic DNA isolated from VA13 cells treated
with the indicated drugs.
(C) VA13 cells treated with the indicated durations of VE-821 were embedded in agarose
plugs and electrophoresed to visualize fragmented DNA with the indicated probes (Tel,
6xCCCTAA; Alu, alu-repeat specific).
(D) VA13 cells treated with the indicated durations of CHIR-124 were embedded in
agarose plugs and electrophoresed to visualize fragmented DNA with the indicated
probes (Tel, 6xCCCTAA; Alu, alu-repeat specific).
(E) Quantification of lane intensity was performed using ImageJ. Values were normalized
to the intensity of 0h time point.
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Figure 18
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Figure 18. γH2Ax is increased following ATR or Chk1 inhibition in LM216ALT and
LM216TEL cells.
(A) LM216ALT and LM216TEL cells were incubated with VE-821 for the indicated
durations, stained for γH2Ax and PI, and analyzed by flow cytometry.
(B) LM216ALT and LM216TEL cells were incubated with CHIR-124 for the indicated
durations, stained for γH2Ax and PI, and analyzed by flow cytometry.
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Figure 19
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Figure 19. Roscovitine and Mus81 knockdown rescues the effects of ATRi and
Chk1i.
(A) VA13 cells treated with the indicated drugs for 24h were embedded in agarose plugs
and electrophoresed to visualize fragmented DNA with the indicated probes (Tel,
6xCCCTAA; Alu, alu-repeat specific).
(B) VA13 cells treated with the indicated drugs for 24h were stained for γH2Ax and PI,
and analyzed by flow cytometry.
(C-D) Rad51/PNA and Hop2/PNA colocalization events were quantified in VA13 cells
treated with the indicated drugs for 24h. For Hop2 analysis, TRF1-FokI virus was added
24h prior to fixation. LY260 represents LY-2603618.
(E-F) Rad51/PNA and Hop2/PNA colocalization events were quantified in VA13 cells
transfected with control or Mus81 siRNA and treated with the indicated drugs for 24h.
For Hop2 analysis, TRF1-FokI virus was added 24h prior to fixation. LY260 represents
LY-2603618.
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Figure 20
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Figure 20. CRISPR-Cas9 mediated deletion of Hop2 suppress ALT phenotypes
(A) Western blotting was performed in VA13 cells selected for expression of the
indicated guide RNAs (sgHop2 a-e).
(B) Representative PNA/Hop2 immuno-FISH images of VA13 parental cells and VA13
cells expressing sgHop2-b.
(C) Representative PNA/PML immuno-FISH images of VA13 parental cells and VA13
cells expressing sgHop2-b.
(D) Number of PML-PNA colocalizations (APBs) per nucleus was quantified in VA13
parental cells and VA13 sgHop2-b cells. *** p < 0.005
(E) Average PNA foci size per nucleus was quantified in VA13 parental cells and VA13
sgHop2-b cells. * p < 0.05
(F) After a BrdU pulse of 2h, % of cells outside of S phase that contained >2 BrdU-PNA
colocalizations was quantified in VA13 parental cells and VA13 sgHop2-b cells. * p <
0.05
(G) Total number of signal exchanges from CO-FISH assay was quantified in VA13
parental cells and VA13 sgHop2-b cells. ** p <0.005
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Movies
Movie 1. Live cell imaging of telomeres after DSB induction demonstrates
movement and clustering. Representative U2OS nucleus expressing mCherry-ER-DDTRF1-FokIWT, Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2
minutes, and each frame represents the stack as a projection onto a single plane. mCherry
signals appear in white, while the colored lines track the path traveled by the mCherry
focus.
Movie 2. Live cell imaging of telomeres in the absence of DSBs. Representative U2OS
nucleus expressing the nuclease-inactive mCherry-ER-DD-TRF1-FokID450A. Cells
were induced for 60 minutes with 4-OHT and Shield1 ligand, then imaged for the
following 60 minutes. Z stacks of mCherry signals were acquired every 2 minutes, and
each frame represents the stack as a projection onto a single plane. mCherry signals
appear in white, while the colored lines track the path traveled by the mCherry focus.
Movie 3. Example of spontaneous telomere clustering. Representative U2OS cell
nucleus with induction of the mCherry-ER-DD-TRF1only protein by 4-OHT and Shield1
ligand. Images were acquired as Z stacks every 2 minutes, and each frame represents the
stack as a projection onto a single plane. White box highlights a spontaneous telomere
association event.
Movie 4. Live cell imaging of mCherry-TRF1FokI foci and interconnecting GFPRad51 filaments in a VA13 cell. An example of a telomere clustering event with an
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interconnecting GFP-Rad51 filament. Images were acquired as Z stacks every 4 minutes,
and each frame represents the stack as a projection onto a single plane.
Movie 5. Live cell imaging of telomeres in U2OS transfected with control siRNA.
mCherry-ER-DD-TRF1-FokI WT was transfected at 48h following transfection with
control siRNA and imaging performed 16 hours later. Cells were induced for 60 minutes
with 4-OHT and Shield1 ligand, then imaged for the following 60 minutes. Z stacks of
mCherry signals were acquired every 2 minutes, and each frame represents the stack as a
projection onto a single plane.
Movie 6. Live cell imaging of telomeres in U2OS transfected with siRNA targeted to
Rad51 demonstrates reduced movement. mCherry-ER-DD-TRF1-FokI WT was
transfected at 48h following transfection with siRad51 #2, and imaging performed 16
hours later. Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2
minutes, and each frame represents the stack as a projection onto a single plane.
Movie 7. Live cell imaging of telomeres in U2OS transfected with siRNA targeted to
Hop2 demonstrates reduced movement. mCherry-ER-DD-TRF1-FokI WT was
transfected at 48h following transfection with siHop2 #2, and imaging performed 16
hours later. Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2
minutes, and each frame represents the stack as a projection onto a single plane.
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